51
|
Park JH, Heo SH, Lee MH, Kwon HS, Kwon SU, Lee JS. White matter hyperintensities and recurrent stroke risk in patients with stroke with small-vessel disease. Eur J Neurol 2019; 26:911-918. [PMID: 30637882 DOI: 10.1111/ene.13908] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2018] [Accepted: 01/08/2019] [Indexed: 11/30/2022]
Abstract
BACKGROUND AND PURPOSE White matter hyperintensities (WMH) are a predictor of stroke among elderly individuals. This study aimed to evaluate the association between WMH severity and the risk of recurrent vascular events among Asian patients with ischaemic stroke with small-vessel disease (SVD) including micro/macrobleeds and lacunes. METHODS Data from participants (n = 1454) in the PICASSO (PreventIon of CArdiovascular Events in iSchemic Stroke Patients with High Risk of Cerebral HemOrrhage) trial were reviewed. The severity of WMH in baseline brain magnetic resonance imaging scans was assessed using the Fazekas scale. The association between WMH severity and stroke (ischaemic or hemorrhagic) and major vascular events (MVEs) (a composite of stroke/myocardial infarction/vascular death) was assessed. RESULTS Study patients had a significant burden of SVD: Fazekas score 0 (n = 2), 1 (n = 426), 2 (n = 650) and 3 (n = 376) [median Fazekas score 2 (mean follow-up, 1.9 ± 1.3 years)]. The stroke incidence rate per 100 personyears was 2.6 in the Fazekas 0-1 group, 3.6 in the Fazekas 2 group and 7.0 in the Fazekas 3 group, and the rates for MVEs were 3.3, 4.3 and 7.6, respectively. Compared with the Fazekas 0-1 group, the Fazekas 3 group was associated with a higher risk of stroke [adjusted hazard ratio (HR), 2.15; 95% confidence interval (CI), 1.19-3.88; P = 0.011], ischaemic stroke (adjusted HR, 2.11; 95% CI, 1.07-4.15; P = 0.031), hemorrhagic stroke (adjusted HR, 3.72; 95% CI, 1.09-12.70; P = 0.036) and MVEs (adjusted HR, 2.09; 95% CI, 1.20-3.66; P = 0.010). CONCLUSION Advanced WMH in Asian patients with ischaemic stroke with SVD burden was associated with an increased risk of recurrent vascular events. It may exert an effect as a prognostic indicator in high risk of recurrent vascular events.
Collapse
Affiliation(s)
- J-H Park
- Department of Neurology, Myongji Hospital, Hanyang University College of Medicine, Goyang
| | - S H Heo
- Department of Neurology, Kyung Hee University Hospital, Seoul
| | - M H Lee
- Department of Neurology, Myongji St Mary's Hospital, Seoul
| | - H S Kwon
- Department of Neurology, Hanyang University College of Medicine, Seoul
| | - S U Kwon
- Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul
| | - J S Lee
- Clinical Research Center, Asan Medical Center, Seoul, South Korea
| | | |
Collapse
|
52
|
Lee JS, An JM, Kang EA, Han YM, Kim YS, Lee HJ, Kim KJ, Surh YJ, Hahm KB. Host nuclear factor erythroid 2-related factor-2 defense system determines the outcome of dextran sulfate sodium-induced colitis in mice. J Physiol Pharmacol 2019; 69. [PMID: 30683827 DOI: 10.26402/jpp.2018.5.10] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Received: 10/16/2018] [Accepted: 10/30/2018] [Indexed: 11/03/2022]
Abstract
Administration of dextran sulfate sodium (DSS) in drinking water led to significant bout of colitis simulating ulcerative colitis of human. However, colitis usually developed 5 - 7 days after DSS administration. Therefore, we hypothesized host defense system might protect colitis up to 5 days of DSS administration. 2.5% DSS-induced colitis were administered to C57BL/6 mice and sequential measurements of pathology, cyclooxygenase-2 (COX-2), nuclear factor-κB (NF-κB), heme oxygenase-1 (HO-1), NADPH quinone oxidoreductase-1 (NQO1), γ-glutamylcysteine synthetase (γ-GCS), nuclear factor erythroid 2-related factor-2 (Nrf2), and keap1 were done at 2, 6, 12, 24, 48, 96, 120, and 168 hour of DSS administration, respectively. DSS-induced colitis was repeated in either COX-2-/- or Nrf2-/- mice. On serial pathological analysis, significant colitis was noted after 120 h of DSS administration, during which both activations of COX-2/NF-κB and HO-1/Nrf2 were noted. Nrf2 activations after keap1 inactivation led to significant increases in HO-1 after 168 hours of DSS administration, when NF-κB nuclear translocation was noted. Significantly attenuated colitis was noted in DSS-challenged COX-2-/- mice, in which the levels of HO-1 were significantly decreased compared to DSS-challenged WT littermates (p < 0.01), while the levels of NQO1 were significantly increased. On DSS administration to Nrf2-/- mice, colitis was significantly aggravated (p < 0.01), in which the expressions of COX-2 as well as expressions of HO-1 and γ-GCS were significantly increased (p < 0.01). Reciprocal activations of inflammatory and antioxidative defense signaling after DSS administration might be prerequisite to make intestinal homeostasis and host defense Nrf2 system can determine colitis.
Collapse
Affiliation(s)
- J S Lee
- Jeonju University, College of Biotechnology and Functional Foods, Jeonju, Korea
| | - J M An
- CHA Cancer Prevention Research Center, CHA Bio Complex, Pangyo, Korea
| | - E A Kang
- CHA Cancer Prevention Research Center, CHA Bio Complex, Pangyo, Korea
| | - Y M Han
- CHA Cancer Prevention Research Center, CHA Bio Complex, Pangyo, Korea
| | - Y S Kim
- Department of Biochemistry and Molecular Biology, Hanyang University School of Medicine, Seoul, Korea
| | - H J Lee
- Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Korea
| | - K-J Kim
- Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
| | - Y J Surh
- College of Pharmacy, Seoul National University, Seoul, Korea
| | - K-B Hahm
- CHA Cancer Prevention Research Center, CHA Bio Complex, Pangyo, Korea. .,Digestive Disease Center, CHA University Bundang Medical Center, Seongnam, Korea
| |
Collapse
|
53
|
Yoo J, Lee JS, Kim S, Kim BS, Choi H, Song DY, Kim WB, Won CW. Length of hospital stay after hip fracture surgery and 1-year mortality. Osteoporos Int 2019; 30:145-153. [PMID: 30361752 DOI: 10.1007/s00198-018-4747-7] [Citation(s) in RCA: 36] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/14/2018] [Accepted: 10/18/2018] [Indexed: 11/30/2022]
Abstract
UNLABELLED There is ongoing effort to discharge patients early after hip fracture surgery to reduce the medical and economic burden. We tried to find whether there is any related side effect, and discovered that early discharge, especially before 10 days after surgery, is associated with higher mortality. INTRODUCTION The aim of this study was to analyze the association between the length of hospital stay after hip fracture and 1-year mortality in older adults aged ≥ 65 years old. METHODS We conducted a retrospective cohort study using the Korean National Health Insurance Service data to identify patients who were discharged after hip fracture surgery from 2007 to 2009 among 487,460 older adults of age ≥ 65 years. The lengths of stay involving hip fracture surgery were categorized at 10-day interval, and analyzed in relation to 1-year mortality from the date of hospital discharge. RESULTS A total of 4213 patients were discharged after hip fracture surgery, of whom 604 (14.3%) died within 1 year of discharge. The average length of stay was 30.7 days (standard deviation 24.5 days). The 1-year mortality was the highest for the length of stay ≤ 10 days group at 21.7%, followed by 15.2%, 14.3%, 13.3%, and 12.4% for > 40, 21-30, 31-40, and 11-20 days groups, respectively (p value 0.05). On Cox proportional hazard regression, the adjusted hazard ratio for length of stay ≤ 10 days group was 1.56 (95% confidence interval 1.14-2.12) against the reference group (11-20 days), while other groups did not show statistical significance. Higher risk of death was associated with increasing age, male gender, Charlson comorbidity index ≥3, subtrochanteric fracture, and discharge to tertiary care hospitals and long-term care hospitals. CONCLUSION Older adults discharged within 10 days of hospital admission for hip fracture surgery have higher 1-year mortality after discharge.
Collapse
Affiliation(s)
- J Yoo
- Department of Family Medicine, College of Medicine, Kyung Hee University, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul, South Korea
| | - J S Lee
- Clinical Research Center, Asan Medical Center, 88, 43-gil Olympic-ro, Songpa-gu, Seoul, South Korea
| | - S Kim
- Department of Family Medicine, College of Medicine, Kyung Hee University, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul, South Korea
| | - B S Kim
- Department of Family Medicine, College of Medicine, Kyung Hee University, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul, South Korea
| | - H Choi
- Department of Family Medicine, College of Medicine, Kyung Hee University, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul, South Korea
| | - D Y Song
- Elderly Frailty Research Center, Kyung Hee University, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul, South Korea
| | - W B Kim
- Department of Medicine, Graduate School, Kyung Hee University, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul, South Korea
| | - C W Won
- Department of Family Medicine, College of Medicine, Kyung Hee University, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul, South Korea.
| |
Collapse
|
54
|
Goh CJ, Park D, Lee JS, Sebastiani F, Hahn Y. Identification of a novel plant amalgavirus (Amalgavirus, Amalgaviridae) genome sequence in Cistus incanus. Acta Virol 2018; 62:122-128. [PMID: 29895152 DOI: 10.4149/av_2018_201] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Amalgaviridae is a family of double-stranded, monosegmented RNA viruses that are associated with plants, fungi, microsporidians, and animals. A sequence contig derived from the transcriptome of a eudicot, Cistus incanus (the family Cistaceae; commonly known as hoary rockrose), was identified as the genome sequence of a novel plant RNA virus and named Cistus incanus RNA virus 1 (CiRV1). Sequence comparison and phylogenetic analysis indicated that CiRV1 is a novel species of the genus Amalgavirus in the family Amalgaviridae. The CiRV1 genome contig has two overlapping open reading frames (ORFs). ORF1 encodes a putative replication factory matrix-like protein, while ORF2 encodes a RNA-dependent RNA polymerase (RdRp) domain. An ORF1+2 fusion protein, which functions in viral RNA replication, is produced by a +1 programmed ribosomal frameshifting (PRF) mechanism. A +1 PRF motif UUU_CGU, which matches the conserved amalgavirus +1 PRF consensus sequence UUU_CGN, was found at the boundary of CiRV1 ORF1 and ORF2. Comparison of 25 amalgavirus ORF1+2 fusion proteins revealed that only three different positions within a 13-amino acid segment were recurrently used at the boundary, possibly being selected so as not to interfere with correct folding and function of the fusion protein. CiRV1 is the first virus found to be associated with the Cistus species and may be useful for studying amalgaviruses.
Collapse
|
55
|
Lee JS, Kim JM, Kim KS, Choi GS, Joh JW, Lee SK. Predictors of incisional hernia in adult liver transplant recipients. Hernia 2018; 23:61-65. [PMID: 30406851 DOI: 10.1007/s10029-018-1845-6] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2018] [Accepted: 10/29/2018] [Indexed: 01/14/2023]
Abstract
PURPOSE Incisional hernia is a complication following abdominal operation. Patients undergoing liver transplantation have a high risk of developing incisional hernia because of immunosuppression. The purpose of this study was to evaluate incisional hernia after liver transplantation and to identify risk factors for hernia formation in those patients. METHODS We retrospectively reviewed 1044 adult patients with more than 2 years of follow-up in patients who underwent liver transplantation from January 2000 to December 2015. RESULTS Incisional hernia was identified in 79 patients with more than 2 years of follow-up. The overall incisional hernia rate was 7.6%. The mean age and body mass index (BMI) of the patients with incisional hernia were 55 ± 9 years and 25.3 ± 3.7 kg/m2, respectively. No significant differences in gender, diagnosis, diabetes, Child-Pugh score, model for end-stage liver disease (MELD) score, donor type, hepatorenal syndrome, varix bleeding, ascites, hepatic encephalopathy, ventilator use, spontaneous bacterial peritonitis (SBP), or bile leakage were found between patients who did and did not develop incisional hernia. Patients with acute rejection before hernia development were more to have herniated patients hernia (p < 0.05). CONCLUSION Age greater than 55 years and high BMI were significant risk factors. We identified risk factors for the development of incisional hernia. Based on these risk factors, attention should be paid to incisional hernia in older and obese patients.
Collapse
Affiliation(s)
- J S Lee
- Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea
| | - J M Kim
- Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea.
| | - K S Kim
- Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea
| | - G-S Choi
- Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea
| | - J-W Joh
- Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea
| | - S-K Lee
- Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea
| |
Collapse
|
56
|
Lee JS, Park HS, Yoon HS, Cho S. Claudin-1 expression decreases with increasing pathological grade in actinic keratosis and may be a marker of high-risk actinic keratosis. Clin Exp Dermatol 2018; 44:483-490. [PMID: 30315595 DOI: 10.1111/ced.13810] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/08/2018] [Indexed: 11/29/2022]
Abstract
BACKGROUND Actinic keratosis (AK) is a common sun-induced skin disorder that can progress to invasive squamous cell carcinoma. However, there is still no reliable method to predict high-risk AK. AIM To identify markers that reflect the biological behaviour of AK and to understand the pathogenesis of AK. METHODS In total, 52 patients with AK and 17 site-matched healthy controls (HCs) were enrolled. We evaluated solar elastosis and immunohistochemical features using antibodies to p53, vitamin D receptor (VDR), claudin-1 and Langerin (CD207). Comparisons between AK and HC skin were performed and analyses carried out according to the pathological grade of AK. RESULTS We found that in both patients and HCs, solar elastosis increased and Langerhans cell (LC) density decreased with ageing. Solar elastosis and p53 expression were higher and VDR expression was lower in patients than in HCs; however, there was no statistical difference between them in relation to the pathological grade of AK. Claudin-1 expression gradually decreased from HC skin to severe AK, and particularly decreased in areas with epidermal atypia. LC density in severe AK was significantly lower than in HC skin and mild AK, while there was no difference in LC density between HC skin, mild AK and moderate AK. CONCLUSIONS Claudin-1 could be a useful marker of the pathological severity of AK. In addition, p53 increases and VDR decreases in AK, not in a gradual manner but in the early steps of carcinogenesis. LC density is relatively maintained in AK until it reaches severe dysplasia.
Collapse
Affiliation(s)
- J S Lee
- Department of Dermatology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Korea.,Institute of Human-Environmental Interface Biology, Medical Research Center, Seoul National University, Seoul, Korea.,Deparment of Biomedical Science
| | - H S Park
- Department of Dermatology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Korea.,Institute of Human-Environmental Interface Biology, Medical Research Center, Seoul National University, Seoul, Korea.,Deparment of Biomedical Science
| | - H S Yoon
- Department of Dermatology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Korea.,Institute of Human-Environmental Interface Biology, Medical Research Center, Seoul National University, Seoul, Korea.,Deparment of Biomedical Science
| | - S Cho
- Department of Dermatology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Korea.,Institute of Human-Environmental Interface Biology, Medical Research Center, Seoul National University, Seoul, Korea.,Deparment of Biomedical Science.,Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea
| |
Collapse
|
57
|
Abstract
Nuchal-type fibroma (NTF) is a rare, benign, tumour-like fibrous proliferation of unknown pathogenesis. Despite the name, approximately one-third of cases occur at extranuchal sites. We report a rare case of NTF of the sacral region, an extremely uncommon extranuchal site. As NTF is often misdiagnosed because of its rarity and histopathological similarity with other fibrous tumours, we present this case to increase understanding of this rare disease entity.
Collapse
Affiliation(s)
- J S Lee
- Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea.,Institute of Human-Environment Interface Biology, Seoul National University, Seoul, Korea
| | - J-H Mun
- Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea.,Institute of Human-Environment Interface Biology, Seoul National University, Seoul, Korea
| |
Collapse
|
58
|
Moyer RA, Bykov I, Orlov DM, Evans TE, Lee JS, Teklu AM, Fenstermacher ME, Makowski M, Lasnier CJ, Wang HQ, Watkins JG, Wu W. Imaging divertor strike point splitting in RMP ELM suppression experiments in the DIII-D tokamak. Rev Sci Instrum 2018; 89:10E106. [PMID: 30399795 DOI: 10.1063/1.5038350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/02/2018] [Accepted: 06/08/2018] [Indexed: 06/08/2023]
Abstract
Fast visible imaging of the lower divertor from above is used to study the structure and dynamics of lobes induced by resonant magnetic perturbations (RMPs) in Edge-Localized Mode (ELM) suppression experiments in DIII-D. The best compromise between the amount of light and sharp imaging was obtained using emission at 601 nm from Fulcher band molecular deuterium. Multiple spatially resolved peaks in the D2 emission, taken as a proxy for the particle flux, are readily resolved during RMPs, in contrast to the heat flux measured by infrared cameras, which shows little spatial structure in ITER-like conditions. The 25 mm objective lens provides high spatial resolution (2-4 mm/pixel) from the centerpost to the outer shelf over 40° toroidally that overlaps the field of view of the IRTV that measures the divertor heat flux, allowing direct comparison in non-axisymmetric discharges. The image is coupled to a Phantom 7.3 camera using a Schott wound fiber bundle, providing high temporal resolution that allows the lobe dynamics to be resolved between ELMs and across ELM suppression onset. These measurements are used to study the heat and particle flux in 3D magnetic fields and to validate models for the plasma response to RMPs.
Collapse
Affiliation(s)
- R A Moyer
- Center for Energy Research, University of California San Diego, La Jolla, California 92093-0417, USA
| | - I Bykov
- Center for Energy Research, University of California San Diego, La Jolla, California 92093-0417, USA
| | - D M Orlov
- Center for Energy Research, University of California San Diego, La Jolla, California 92093-0417, USA
| | - T E Evans
- General Atomics, San Diego, California 92186-5608, USA
| | - J S Lee
- University of California, Los Angeles, Los Angeles, California 90095, USA
| | - A M Teklu
- Oregon State University, Corvallis, Oregon 97331, USA
| | - M E Fenstermacher
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - M Makowski
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - C J Lasnier
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - H Q Wang
- Oak Ridge Associated Universities, Oak Ridge, Tennessee 37831, USA
| | - J G Watkins
- Sandia National Laboratories, California, Livermore, California 94551-0969, USA
| | - W Wu
- General Atomics, San Diego, California 92186-5608, USA
| |
Collapse
|
59
|
Kim TJ, Lee JS, Kang MK, Nam KW, Lee CH, Mo H, Jeong HY, Yoon BW, Ko SB. Clopidogrel may decrease the risk of post-stroke infection after ischaemic stroke. Eur J Neurol 2018; 26:261-267. [PMID: 30168901 DOI: 10.1111/ene.13801] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2018] [Accepted: 08/28/2018] [Indexed: 01/09/2023]
Abstract
BACKGROUND AND PURPOSE The P2Y12 receptor, a well-known factor in the platelet activation pathway, plays a role in thrombosis as well as systemic inflammation. Clopidogrel, a prototype P2Y12 receptor antagonist, reportedly decreases inflammation and systemic infection. The aim of this study was to evaluate whether clopidogrel use decreases the risk of post-stroke infection following ischaemic stroke. METHODS A total of 1643 patients with acute ischaemic stroke (within 7 days after onset) were included for analysis between March 2010 and December 2015. Patients were categorized into two groups (clopidogrel users versus clopidogrel non-users), and clinical characteristics and risks of post-stroke infection were compared between the two groups. The inverse probability of treatment weighting using propensity scores for baseline imbalance adjustments was applied. RESULTS Of the included patients (mean age 67.7 years; men 60.6%), 670 (40.8%) patients were clopidogrel users and 164 (10.0%) patients had post-stroke infection. The proportion of patients with post-stroke infection was significantly lower in clopidogrel users compared to clopidogrel non-users (6.7% vs. 12.2%, P ≤ 0.001). Moreover, clopidogrel users were less likely to be admitted to the intensive care unit (13.3% vs. 35.3%, P = 0.006). A multivariate analysis with inverse probability of treatment weighting revealed that clopidogrel users exhibited a lower risk of post-stroke infection (odds ratio 0.56, 95% confidence interval 0.42-0.75) and intensive care unit admission (odds ratio 0.34, 95% confidence interval 0.22-0.53). CONCLUSIONS The study suggested that clopidogrel users exhibit a lower risk of infection and develop less severe infections after ischaemic stroke. Further prospective studies are needed.
Collapse
Affiliation(s)
- T J Kim
- Department of Neurology, Seoul National University Hospital, Seoul, Korea
| | - J S Lee
- Clinical Research Center, Asan Medical Center, Seoul, Korea
| | - M-K Kang
- Department of Neurology, Seoul National University Hospital, Seoul, Korea
| | - K-W Nam
- Department of Neurology, Seoul National University Hospital, Seoul, Korea
| | - C-H Lee
- Department of Neurology, Seoul National University Hospital, Seoul, Korea
| | - H Mo
- Department of Neurology, Seoul National University Hospital, Seoul, Korea
| | - H-Y Jeong
- Department of Neurology, Seoul National University Hospital, Seoul, Korea
| | - B-W Yoon
- Department of Neurology, Seoul National University Hospital, Seoul, Korea
| | - S-B Ko
- Department of Neurology, Seoul National University Hospital, Seoul, Korea
| |
Collapse
|
60
|
Su Z, Zarassi A, Hsu JF, San-Jose P, Prada E, Aguado R, Lee EJH, Gazibegovic S, Op Het Veld RLM, Car D, Plissard SR, Hocevar M, Pendharkar M, Lee JS, Logan JA, Palmstrøm CJ, Bakkers EPAM, Frolov SM. Mirage Andreev Spectra Generated by Mesoscopic Leads in Nanowire Quantum Dots. Phys Rev Lett 2018; 121:127705. [PMID: 30296125 DOI: 10.1103/physrevlett.121.127705] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/10/2018] [Indexed: 06/08/2023]
Abstract
We study transport mediated by Andreev bound states formed in InSb nanowire quantum dots. Two kinds of superconducting source and drain contacts are used: epitaxial Al/InSb devices exhibit a doubling of tunneling resonances, while, in NbTiN/InSb devices, Andreev spectra of the dot appear to be replicated multiple times at increasing source-drain bias voltages. In both devices, a mirage of a crowded spectrum is created. To describe the observations a model is developed that combines the effects of a soft induced gap and of additional Andreev bound states both in the quantum dot and in the finite regions of the nanowire adjacent to the quantum dot. Understanding of Andreev spectroscopy is important for the correct interpretation of Majorana experiments done on the same structures.
Collapse
Affiliation(s)
- Z Su
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - A Zarassi
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - J-F Hsu
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - P San-Jose
- Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Cantoblanco, 28049 Madrid, Spain
| | - E Prada
- Departamento de Fisica de la Materia Condensada, Condensed Matter Physics Center (IFIMAC) and Instituto Nicolas Cabrera, Universidad Autonoma de Madrid, E-28049 Madrid, Spain
| | - R Aguado
- Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Cantoblanco, 28049 Madrid, Spain
| | - E J H Lee
- Departamento de Fisica de la Materia Condensada, Condensed Matter Physics Center (IFIMAC) and Instituto Nicolas Cabrera, Universidad Autonoma de Madrid, E-28049 Madrid, Spain
| | - S Gazibegovic
- Eindhoven University of Technology, 5600 MB, Eindhoven, Netherlands
| | | | - D Car
- Eindhoven University of Technology, 5600 MB, Eindhoven, Netherlands
| | - S R Plissard
- LAAS CNRS, Université de Toulouse, 31031 Toulouse, France
| | - M Hocevar
- Univ. Grenoble Alpes, CNRS, Grenoble INP, Institut Néel, 38000 Grenoble, France
| | - M Pendharkar
- Electrical and Computer Engineering, University of California Santa Barbara, Santa Barbara, California 93106, USA
| | - J S Lee
- California NanoSystems Institute, University of California Santa Barbara, Santa Barbara, California 93106, USA
| | - J A Logan
- Materials Department, University of California, Santa Barbara, Santa Barbara, California 93106, USA
| | - C J Palmstrøm
- Electrical and Computer Engineering, University of California Santa Barbara, Santa Barbara, California 93106, USA
- California NanoSystems Institute, University of California Santa Barbara, Santa Barbara, California 93106, USA
- Materials Department, University of California, Santa Barbara, Santa Barbara, California 93106, USA
| | - E P A M Bakkers
- Eindhoven University of Technology, 5600 MB, Eindhoven, Netherlands
| | - S M Frolov
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| |
Collapse
|
61
|
Oh DY, Jung KE, Koo DW, Lee JS. Image Gallery: Squamous cell carcinoma on an untreated vitiligo lesion. Br J Dermatol 2018; 179:e2. [PMID: 30156284 DOI: 10.1111/bjd.16606] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- D Y Oh
- Department of Dermatology, School of Medicine, Eulji University, Daejeon, Korea
| | - K E Jung
- Department of Dermatology, School of Medicine, Eulji University, Daejeon, Korea
| | - D W Koo
- Department of Dermatology, School of Medicine, Eulji University, Daejeon, Korea
| | - J S Lee
- Department of Dermatology, School of Medicine, Eulji University, Daejeon, Korea
| |
Collapse
|
62
|
Lee JH, Lee HK, Kim HS, Kim JS, Ji AY, Lee JS, Kim KS, Lee TY, Bae SC, Kim Y, Hong JT, Han SB. CXCR3-deficient mesenchymal stem cells fail to infiltrate into the nephritic kidney and do not ameliorate lupus symptoms in MRL. Fas lpr mice. Lupus 2018; 27:1854-1859. [PMID: 30139297 DOI: 10.1177/0961203318794871] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Mesenchymal stem cell therapy is a promising candidate for the treatment of systemic lupus erythematosus (SLE). To exert their efficacy fully, mesenchymal stem cells must infiltrate efficiently into the lesion sites. Here, we examined the role of CXCR3 in mesenchymal stem cell infiltration into the kidney of MRL. Faslpr mice, which highly expressed CXCL10. The phenotypes, production of immunosuppressive mediators, and capacity to inhibit T and B cells of CXCR3-deficient mesenchymal stem cells were similar to those of wild-type mesenchymal stem cells. However, they showed less infiltration into the nephritic kidney, less conjugation with endothelial cells and weaker MMP-9 expression than did wild-type mesenchymal stem cells. Consequently, CXCR3-deficient mesenchymal stem cells did not ameliorate lupus symptoms in MRL. Faslpr mice in comparison with wild-type mesenchymal stem cells. In summary, our data suggest that upregulation of CXCR3 in mesenchymal stem cells will be a good strategy to increase their infiltration into the kidney, which will improve therapeutic outcomes in SLE.
Collapse
Affiliation(s)
- J H Lee
- 1 College of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea
| | - H K Lee
- 1 College of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea
| | - H S Kim
- 1 College of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea
| | - J S Kim
- 1 College of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea
| | - A Y Ji
- 1 College of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea
| | - J S Lee
- 1 College of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea
| | - K S Kim
- 2 Bioengineering Institute, Corestem Inc., Gyeonggi, Republic of Korea
| | - T Y Lee
- 2 Bioengineering Institute, Corestem Inc., Gyeonggi, Republic of Korea
| | - S C Bae
- 3 Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea
| | - Y Kim
- 1 College of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea
| | - J T Hong
- 1 College of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea
| | - S B Han
- 1 College of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea
| |
Collapse
|
63
|
Fukui M, Gupta A, Abdelkarim I, Sharbaugh M, Althouse A, Elzomor H, Katz W, Crock F, Kliner D, Lee JS, Schindler JT, Gleason TG, Cavalcante JL. 231Impact of cardiac damage extent on transcatheter aortic valve replacement outcome - a validation of a new staging system. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy564.231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- M Fukui
- University of Pittsburgh, Department of Medicine, Division of Cardiovascular Diseases, Heart & Vascular Institute, UPMC, Pittsburgh, United States of America
| | - A Gupta
- University of Pittsburgh, Department of Medicine, Division of Cardiovascular Diseases, Heart & Vascular Institute, UPMC, Pittsburgh, United States of America
| | - I Abdelkarim
- University of Pittsburgh, Department of Medicine, Division of Cardiovascular Diseases, Heart & Vascular Institute, UPMC, Pittsburgh, United States of America
| | - M Sharbaugh
- University of Pittsburgh, Department of Medicine, Division of Cardiovascular Diseases, Heart & Vascular Institute, UPMC, Pittsburgh, United States of America
| | - A Althouse
- University of Pittsburgh, Department of Medicine, Division of Cardiovascular Diseases, Heart & Vascular Institute, UPMC, Pittsburgh, United States of America
| | - H Elzomor
- University of Pittsburgh, Department of Medicine, Division of Cardiovascular Diseases, Heart & Vascular Institute, UPMC, Pittsburgh, United States of America
| | - W Katz
- University of Pittsburgh, Department of Medicine, Division of Cardiovascular Diseases, Heart & Vascular Institute, UPMC, Pittsburgh, United States of America
| | - F Crock
- University of Pittsburgh, Department of Medicine, Division of Cardiovascular Diseases, Heart & Vascular Institute, UPMC, Pittsburgh, United States of America
| | - D Kliner
- University of Pittsburgh, Department of Medicine, Division of Cardiovascular Diseases, Heart & Vascular Institute, UPMC, Pittsburgh, United States of America
| | - J S Lee
- University of Pittsburgh, Department of Medicine, Division of Cardiovascular Diseases, Heart & Vascular Institute, UPMC, Pittsburgh, United States of America
| | - J T Schindler
- University of Pittsburgh, Department of Medicine, Division of Cardiovascular Diseases, Heart & Vascular Institute, UPMC, Pittsburgh, United States of America
| | - T G Gleason
- University of Pittsburgh, Department of Medicine, Division of Cardiovascular Diseases, Heart & Vascular Institute, UPMC, Pittsburgh, United States of America
| | - J L Cavalcante
- University of Pittsburgh, Department of Medicine, Division of Cardiovascular Diseases, Heart & Vascular Institute, UPMC, Pittsburgh, United States of America
| |
Collapse
|
64
|
Aaltonen T, Amerio S, Amidei D, Anastassov A, Annovi A, Antos J, Apollinari G, Appel JA, Arisawa T, Artikov A, Asaadi J, Ashmanskas W, Auerbach B, Aurisano A, Azfar F, Badgett W, Bae T, Barbaro-Galtieri A, Barnes VE, Barnett BA, Barria P, Bartos P, Bauce M, Bedeschi F, Behari S, Bellettini G, Bellinger J, Benjamin D, Beretvas A, Bhatti A, Bland KR, Blumenfeld B, Bocci A, Bodek A, Bortoletto D, Boudreau J, Boveia A, Brigliadori L, Bromberg C, Brucken E, Budagov J, Budd HS, Burkett K, Busetto G, Bussey P, Butti P, Buzatu A, Calamba A, Camarda S, Campanelli M, Canelli F, Carls B, Carlsmith D, Carosi R, Carrillo S, Casal B, Casarsa M, Castro A, Catastini P, Cauz D, Cavaliere V, Cerri A, Cerrito L, Chen YC, Chertok M, Chiarelli G, Chlachidze G, Cho K, Chokheli D, Clark A, Clarke C, Convery ME, Conway J, Corbo M, Cordelli M, Cox CA, Cox DJ, Cremonesi M, Cruz D, Cuevas J, Culbertson R, d'Ascenzo N, Datta M, de Barbaro P, Demortier L, Deninno M, D'Errico M, Devoto F, Di Canto A, Di Ruzza B, Dittmann JR, Donati S, D'Onofrio M, Dorigo M, Driutti A, Ebina K, Edgar R, Elagin A, Erbacher R, Errede S, Esham B, Farrington S, Fernández Ramos JP, Field R, Flanagan G, Forrest R, Franklin M, Freeman JC, Frisch H, Funakoshi Y, Galloni C, Garfinkel AF, Garosi P, Gerberich H, Gerchtein E, Giagu S, Giakoumopoulou V, Gibson K, Ginsburg CM, Giokaris N, Giromini P, Glagolev V, Glenzinski D, Gold M, Goldin D, Golossanov A, Gomez G, Gomez-Ceballos G, Goncharov M, González López O, Gorelov I, Goshaw AT, Goulianos K, Gramellini E, Grosso-Pilcher C, Guimaraes da Costa J, Hahn SR, Han JY, Happacher F, Hara K, Hare M, Harr RF, Harrington-Taber T, Hatakeyama K, Hays C, Heinrich J, Herndon M, Hocker A, Hong Z, Hopkins W, Hou S, Hughes RE, Husemann U, Hussein M, Huston J, Introzzi G, Iori M, Ivanov A, James E, Jang D, Jayatilaka B, Jeon EJ, Jindariani S, Jones M, Joo KK, Jun SY, Junk TR, Kambeitz M, Kamon T, Karchin PE, Kasmi A, Kato Y, Ketchum W, Keung J, Kilminster B, Kim DH, Kim HS, Kim JE, Kim MJ, Kim SH, Kim SB, Kim YJ, Kim YK, Kimura N, Kirby M, Kondo K, Kong DJ, Konigsberg J, Kotwal AV, Kreps M, Kroll J, Kruse M, Kuhr T, Kurata M, Laasanen AT, Lammel S, Lancaster M, Lannon K, Latino G, Lee HS, Lee JS, Leo S, Leone S, Lewis JD, Limosani A, Lipeles E, Lister A, Liu Q, Liu T, Lockwitz S, Loginov A, Lucchesi D, Lucà A, Lueck J, Lujan P, Lukens P, Lungu G, Lys J, Lysak R, Madrak R, Maestro P, Malik S, Manca G, Manousakis-Katsikakis A, Marchese L, Margaroli F, Marino P, Matera K, Mattson ME, Mazzacane A, Mazzanti P, McNulty R, Mehta A, Mehtala P, Mesropian C, Miao T, Mietlicki D, Mitra A, Miyake H, Moed S, Moggi N, Moon CS, Moore R, Morello MJ, Mukherjee A, Muller T, Murat P, Mussini M, Nachtman J, Nagai Y, Naganoma J, Nakano I, Napier A, Nett J, Nigmanov T, Nodulman L, Noh SY, Norniella O, Oakes L, Oh SH, Oh YD, Okusawa T, Orava R, Ortolan L, Pagliarone C, Palencia E, Palni P, Papadimitriou V, Parker W, Pauletta G, Paulini M, Paus C, Phillips TJ, Piacentino G, Pianori E, Pilot J, Pitts K, Plager C, Pondrom L, Poprocki S, Potamianos K, Pranko A, Prokoshin F, Ptohos F, Punzi G, Redondo Fernández I, Renton P, Rescigno M, Rimondi F, Ristori L, Robson A, Rodriguez T, Rolli S, Ronzani M, Roser R, Rosner JL, Ruffini F, Ruiz A, Russ J, Rusu V, Sakumoto WK, Sakurai Y, Santi L, Sato K, Saveliev V, Savoy-Navarro A, Schlabach P, Schmidt EE, Schwarz T, Scodellaro L, Scuri F, Seidel S, Seiya Y, Semenov A, Sforza F, Shalhout SZ, Shears T, Shepard PF, Shimojima M, Shochet M, Shreyber-Tecker I, Simonenko A, Sliwa K, Smith JR, Snider FD, Song H, Sorin V, St Denis R, Stancari M, Stentz D, Strologas J, Sudo Y, Sukhanov A, Suslov I, Takemasa K, Takeuchi Y, Tang J, Tecchio M, Teng PK, Thom J, Thomson E, Thukral V, Toback D, Tokar S, Tollefson K, Tomura T, Tonelli D, Torre S, Torretta D, Totaro P, Trovato M, Ukegawa F, Uozumi S, Vázquez F, Velev G, Vellidis C, Vernieri C, Vidal M, Vilar R, Vizán J, Vogel M, Volpi G, Wagner P, Wallny R, Wang SM, Waters D, Wester WC, Whiteson D, Wicklund AB, Wilbur S, Williams HH, Wilson JS, Wilson P, Winer BL, Wittich P, Wolbers S, Wolfmeister H, Wright T, Wu X, Wu Z, Yamamoto K, Yamato D, Yang T, Yang UK, Yang YC, Yao WM, Yeh GP, Yi K, Yoh J, Yorita K, Yoshida T, Yu GB, Yu I, Zanetti AM, Zeng Y, Zhou C, Zucchelli S. Search for the Exotic Meson X(5568) with the Collider Detector at Fermilab. Phys Rev Lett 2018; 120:202006. [PMID: 29864341 DOI: 10.1103/physrevlett.120.202006] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/29/2017] [Revised: 03/05/2018] [Indexed: 06/08/2023]
Abstract
A search for the exotic meson X(5568) decaying into the B_{s}^{0}π^{±} final state is performed using data corresponding to 9.6 fb^{-1} from pp[over ¯] collisions at sqrt[s]=1960 GeV recorded by the Collider Detector at Fermilab. No evidence for this state is found and an upper limit of 6.7% at the 95% confidence level is set on the fraction of B_{s}^{0} produced through the X(5568)→B_{s}^{0}π^{±} process.
Collapse
Affiliation(s)
- T Aaltonen
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - S Amerio
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - D Amidei
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - A Anastassov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Annovi
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - J Antos
- Comenius University, 842 48 Bratislava, Slovakia; Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - G Apollinari
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J A Appel
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | - A Artikov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - J Asaadi
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - W Ashmanskas
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - B Auerbach
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - A Aurisano
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - F Azfar
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - W Badgett
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - T Bae
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - A Barbaro-Galtieri
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - V E Barnes
- Purdue University, West Lafayette, Indiana 47907, USA
| | - B A Barnett
- The Johns Hopkins University, Baltimore, Maryland 21218, USA
| | - P Barria
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | - P Bartos
- Comenius University, 842 48 Bratislava, Slovakia; Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - M Bauce
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - F Bedeschi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - S Behari
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Bellettini
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - J Bellinger
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - D Benjamin
- Duke University, Durham, North Carolina 27708, USA
| | - A Beretvas
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Bhatti
- The Rockefeller University, New York, New York 10065, USA
| | - K R Bland
- Baylor University, Waco, Texas 76798, USA
| | - B Blumenfeld
- The Johns Hopkins University, Baltimore, Maryland 21218, USA
| | - A Bocci
- Duke University, Durham, North Carolina 27708, USA
| | - A Bodek
- University of Rochester, Rochester, New York 14627, USA
| | - D Bortoletto
- Purdue University, West Lafayette, Indiana 47907, USA
| | - J Boudreau
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - A Boveia
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - L Brigliadori
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
- University of Bologna, I-40127 Bologna, Italy
| | - C Bromberg
- Michigan State University, East Lansing, Michigan 48824, USA
| | - E Brucken
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - J Budagov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - H S Budd
- University of Rochester, Rochester, New York 14627, USA
| | - K Burkett
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Busetto
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - P Bussey
- Glasgow University, Glasgow G12 8QQ, United Kingdom
| | - P Butti
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - A Buzatu
- Glasgow University, Glasgow G12 8QQ, United Kingdom
| | - A Calamba
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - S Camarda
- Institut de Fisica d'Altes Energies, ICREA, Universitat Autonoma de Barcelona, E-08193, Bellaterra (Barcelona), Spain
| | - M Campanelli
- University College London, London WC1E 6BT, United Kingdom
| | - F Canelli
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - B Carls
- University of Illinois, Urbana, Illinois 61801, USA
| | - D Carlsmith
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - R Carosi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - S Carrillo
- University of Florida, Gainesville, Florida 32611, USA
| | - B Casal
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - M Casarsa
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
| | - A Castro
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
- University of Bologna, I-40127 Bologna, Italy
| | - P Catastini
- Harvard University, Cambridge, Massachusetts 02138, USA
| | - D Cauz
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- Gruppo Collegato di Udine, I-33100 Udine, Italy
- University of Udine, I-33100 Udine, Italy
| | - V Cavaliere
- University of Illinois, Urbana, Illinois 61801, USA
| | - A Cerri
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - L Cerrito
- University College London, London WC1E 6BT, United Kingdom
| | - Y C Chen
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - M Chertok
- University of California, Davis, Davis, California 95616, USA
| | - G Chiarelli
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - G Chlachidze
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Cho
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - D Chokheli
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - A Clark
- University of Geneva, CH-1211 Geneva 4, Switzerland
| | - C Clarke
- Wayne State University, Detroit, Michigan 48201, USA
| | - M E Convery
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Conway
- University of California, Davis, Davis, California 95616, USA
| | - M Corbo
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Cordelli
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - C A Cox
- University of California, Davis, Davis, California 95616, USA
| | - D J Cox
- University of California, Davis, Davis, California 95616, USA
| | - M Cremonesi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - D Cruz
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - J Cuevas
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - R Culbertson
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - N d'Ascenzo
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Datta
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P de Barbaro
- University of Rochester, Rochester, New York 14627, USA
| | - L Demortier
- The Rockefeller University, New York, New York 10065, USA
| | - M Deninno
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - M D'Errico
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - F Devoto
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - A Di Canto
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - B Di Ruzza
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | - S Donati
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - M D'Onofrio
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - M Dorigo
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- University of Trieste, I-34127 Trieste, Italy
| | - A Driutti
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- Gruppo Collegato di Udine, I-33100 Udine, Italy
- University of Udine, I-33100 Udine, Italy
| | - K Ebina
- Waseda University, Tokyo 169, Japan
| | - R Edgar
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - A Elagin
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - R Erbacher
- University of California, Davis, Davis, California 95616, USA
| | - S Errede
- University of Illinois, Urbana, Illinois 61801, USA
| | - B Esham
- University of Illinois, Urbana, Illinois 61801, USA
| | - S Farrington
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - J P Fernández Ramos
- Centro de Investigaciones Energeticas Medioambientales y Tecnologicas, E-28040 Madrid, Spain
| | - R Field
- University of Florida, Gainesville, Florida 32611, USA
| | - G Flanagan
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Forrest
- University of California, Davis, Davis, California 95616, USA
| | - M Franklin
- Harvard University, Cambridge, Massachusetts 02138, USA
| | - J C Freeman
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - H Frisch
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | | | - C Galloni
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - A F Garfinkel
- Purdue University, West Lafayette, Indiana 47907, USA
| | - P Garosi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | - H Gerberich
- University of Illinois, Urbana, Illinois 61801, USA
| | - E Gerchtein
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Giagu
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
| | | | - K Gibson
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - C M Ginsburg
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - N Giokaris
- University of Athens, 157 71 Athens, Greece
| | - P Giromini
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - V Glagolev
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - D Glenzinski
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Gold
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - D Goldin
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - A Golossanov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Gomez
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - G Gomez-Ceballos
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - M Goncharov
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - O González López
- Centro de Investigaciones Energeticas Medioambientales y Tecnologicas, E-28040 Madrid, Spain
| | - I Gorelov
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - A T Goshaw
- Duke University, Durham, North Carolina 27708, USA
| | - K Goulianos
- The Rockefeller University, New York, New York 10065, USA
| | - E Gramellini
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - C Grosso-Pilcher
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | | | - S R Hahn
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Y Han
- University of Rochester, Rochester, New York 14627, USA
| | - F Happacher
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - K Hara
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - M Hare
- Tufts University, Medford, Massachusetts 02155, USA
| | - R F Harr
- Wayne State University, Detroit, Michigan 48201, USA
| | | | | | - C Hays
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - J Heinrich
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - M Herndon
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - A Hocker
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Z Hong
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - W Hopkins
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Hou
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - R E Hughes
- The Ohio State University, Columbus, Ohio 43210, USA
| | - U Husemann
- Yale University, New Haven, Connecticut 06520, USA
| | - M Hussein
- Michigan State University, East Lansing, Michigan 48824, USA
| | - J Huston
- Michigan State University, East Lansing, Michigan 48824, USA
| | - G Introzzi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- INFN Pavia, I-27100 Pavia, Italy
| | - M Iori
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
- Sapienza Università di Roma, I-00185 Roma, Italy
| | - A Ivanov
- University of California, Davis, Davis, California 95616, USA
| | - E James
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Jang
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - B Jayatilaka
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - E J Jeon
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - S Jindariani
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Jones
- Purdue University, West Lafayette, Indiana 47907, USA
| | - K K Joo
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - S Y Jun
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - T R Junk
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Kambeitz
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - T Kamon
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - P E Karchin
- Wayne State University, Detroit, Michigan 48201, USA
| | - A Kasmi
- Baylor University, Waco, Texas 76798, USA
| | - Y Kato
- Osaka City University, Osaka 558-8585, Japan
| | - W Ketchum
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - J Keung
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - B Kilminster
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D H Kim
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - H S Kim
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J E Kim
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - M J Kim
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - S H Kim
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - S B Kim
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - Y J Kim
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - Y K Kim
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - N Kimura
- Waseda University, Tokyo 169, Japan
| | - M Kirby
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Kondo
- Waseda University, Tokyo 169, Japan
| | - D J Kong
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - J Konigsberg
- University of Florida, Gainesville, Florida 32611, USA
| | - A V Kotwal
- Duke University, Durham, North Carolina 27708, USA
| | - M Kreps
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - J Kroll
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - M Kruse
- Duke University, Durham, North Carolina 27708, USA
| | - T Kuhr
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - M Kurata
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - A T Laasanen
- Purdue University, West Lafayette, Indiana 47907, USA
| | - S Lammel
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Lancaster
- University College London, London WC1E 6BT, United Kingdom
| | - K Lannon
- The Ohio State University, Columbus, Ohio 43210, USA
| | - G Latino
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | - H S Lee
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - J S Lee
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - S Leo
- University of Illinois, Urbana, Illinois 61801, USA
| | - S Leone
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - J D Lewis
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Limosani
- Duke University, Durham, North Carolina 27708, USA
| | - E Lipeles
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - A Lister
- University of Geneva, CH-1211 Geneva 4, Switzerland
| | - Q Liu
- Purdue University, West Lafayette, Indiana 47907, USA
| | - T Liu
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Lockwitz
- Yale University, New Haven, Connecticut 06520, USA
| | - A Loginov
- Yale University, New Haven, Connecticut 06520, USA
| | - D Lucchesi
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - A Lucà
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - J Lueck
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - P Lujan
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - P Lukens
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Lungu
- The Rockefeller University, New York, New York 10065, USA
| | - J Lys
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - R Lysak
- Comenius University, 842 48 Bratislava, Slovakia; Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - R Madrak
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Maestro
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | - S Malik
- The Rockefeller University, New York, New York 10065, USA
| | - G Manca
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | | | - L Marchese
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - F Margaroli
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
| | - P Marino
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- Scuola Normale Superiore, I-56127 Pisa, Italy
| | - K Matera
- University of Illinois, Urbana, Illinois 61801, USA
| | - M E Mattson
- Wayne State University, Detroit, Michigan 48201, USA
| | - A Mazzacane
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Mazzanti
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - R McNulty
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - A Mehta
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - P Mehtala
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - C Mesropian
- The Rockefeller University, New York, New York 10065, USA
| | - T Miao
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Mietlicki
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - A Mitra
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - H Miyake
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - S Moed
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - N Moggi
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - C S Moon
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Moore
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M J Morello
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- Scuola Normale Superiore, I-56127 Pisa, Italy
| | - A Mukherjee
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Th Muller
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - P Murat
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Mussini
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
- University of Bologna, I-40127 Bologna, Italy
| | - J Nachtman
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Y Nagai
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | | | - I Nakano
- Okayama University, Okayama 700-8530, Japan
| | - A Napier
- Tufts University, Medford, Massachusetts 02155, USA
| | - J Nett
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - T Nigmanov
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - L Nodulman
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - S Y Noh
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - O Norniella
- University of Illinois, Urbana, Illinois 61801, USA
| | - L Oakes
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - S H Oh
- Duke University, Durham, North Carolina 27708, USA
| | - Y D Oh
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - T Okusawa
- Osaka City University, Osaka 558-8585, Japan
| | - R Orava
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - L Ortolan
- Institut de Fisica d'Altes Energies, ICREA, Universitat Autonoma de Barcelona, E-08193, Bellaterra (Barcelona), Spain
| | - C Pagliarone
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
| | - E Palencia
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - P Palni
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - V Papadimitriou
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - W Parker
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - G Pauletta
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- Gruppo Collegato di Udine, I-33100 Udine, Italy
- University of Udine, I-33100 Udine, Italy
| | - M Paulini
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - C Paus
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - T J Phillips
- Duke University, Durham, North Carolina 27708, USA
| | - G Piacentino
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - E Pianori
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - J Pilot
- University of California, Davis, Davis, California 95616, USA
| | - K Pitts
- University of Illinois, Urbana, Illinois 61801, USA
| | - C Plager
- University of California, Los Angeles, Los Angeles, California 90024, USA
| | - L Pondrom
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - S Poprocki
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Potamianos
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - A Pranko
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - F Prokoshin
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - F Ptohos
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - G Punzi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - I Redondo Fernández
- Centro de Investigaciones Energeticas Medioambientales y Tecnologicas, E-28040 Madrid, Spain
| | - P Renton
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - M Rescigno
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
| | - F Rimondi
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - L Ristori
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - A Robson
- Glasgow University, Glasgow G12 8QQ, United Kingdom
| | - T Rodriguez
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - S Rolli
- Tufts University, Medford, Massachusetts 02155, USA
| | - M Ronzani
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - R Roser
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J L Rosner
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - F Ruffini
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | - A Ruiz
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - J Russ
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - V Rusu
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - W K Sakumoto
- University of Rochester, Rochester, New York 14627, USA
| | | | - L Santi
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- Gruppo Collegato di Udine, I-33100 Udine, Italy
- University of Udine, I-33100 Udine, Italy
| | - K Sato
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - V Saveliev
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Savoy-Navarro
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Schlabach
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - E E Schmidt
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - T Schwarz
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - L Scodellaro
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - F Scuri
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - S Seidel
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - Y Seiya
- Osaka City University, Osaka 558-8585, Japan
| | - A Semenov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - F Sforza
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - S Z Shalhout
- University of California, Davis, Davis, California 95616, USA
| | - T Shears
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - P F Shepard
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - M Shimojima
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - M Shochet
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - I Shreyber-Tecker
- Institution for Theoretical and Experimental Physics, ITEP, Moscow 117259, Russia
| | - A Simonenko
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - K Sliwa
- Tufts University, Medford, Massachusetts 02155, USA
| | - J R Smith
- University of California, Davis, Davis, California 95616, USA
| | - F D Snider
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - H Song
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - V Sorin
- Institut de Fisica d'Altes Energies, ICREA, Universitat Autonoma de Barcelona, E-08193, Bellaterra (Barcelona), Spain
| | - R St Denis
- Glasgow University, Glasgow G12 8QQ, United Kingdom
| | - M Stancari
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Stentz
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Strologas
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - Y Sudo
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - A Sukhanov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - I Suslov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - K Takemasa
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - Y Takeuchi
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - J Tang
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - M Tecchio
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - P K Teng
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - J Thom
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - E Thomson
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - V Thukral
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - D Toback
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - S Tokar
- Comenius University, 842 48 Bratislava, Slovakia; Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - K Tollefson
- Michigan State University, East Lansing, Michigan 48824, USA
| | - T Tomura
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - D Tonelli
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Torre
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - D Torretta
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Totaro
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
| | - M Trovato
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- Scuola Normale Superiore, I-56127 Pisa, Italy
| | - F Ukegawa
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - S Uozumi
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - F Vázquez
- University of Florida, Gainesville, Florida 32611, USA
| | - G Velev
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - C Vellidis
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - C Vernieri
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- Scuola Normale Superiore, I-56127 Pisa, Italy
| | - M Vidal
- Purdue University, West Lafayette, Indiana 47907, USA
| | - R Vilar
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - J Vizán
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - M Vogel
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - G Volpi
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - P Wagner
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - R Wallny
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S M Wang
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - D Waters
- University College London, London WC1E 6BT, United Kingdom
| | - W C Wester
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Whiteson
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - A B Wicklund
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - S Wilbur
- University of California, Davis, Davis, California 95616, USA
| | - H H Williams
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - J S Wilson
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - P Wilson
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - B L Winer
- The Ohio State University, Columbus, Ohio 43210, USA
| | - P Wittich
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Wolbers
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - H Wolfmeister
- The Ohio State University, Columbus, Ohio 43210, USA
| | - T Wright
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - X Wu
- University of Geneva, CH-1211 Geneva 4, Switzerland
| | - Z Wu
- Baylor University, Waco, Texas 76798, USA
| | - K Yamamoto
- Osaka City University, Osaka 558-8585, Japan
| | - D Yamato
- Osaka City University, Osaka 558-8585, Japan
| | - T Yang
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - U K Yang
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - Y C Yang
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - W-M Yao
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - G P Yeh
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Yi
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Yoh
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Yorita
- Waseda University, Tokyo 169, Japan
| | - T Yoshida
- Osaka City University, Osaka 558-8585, Japan
| | - G B Yu
- Duke University, Durham, North Carolina 27708, USA
| | - I Yu
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul, 120-750, Korea
| | - A M Zanetti
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
| | - Y Zeng
- Duke University, Durham, North Carolina 27708, USA
| | - C Zhou
- Duke University, Durham, North Carolina 27708, USA
| | - S Zucchelli
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
- University of Bologna, I-40127 Bologna, Italy
| |
Collapse
|
65
|
Lee CW, Lee JS, Woo CW, Kim S. High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance Spectroscopy for the Metabolic Assessment of Acute Rejection After Cardiac Transplantation in Rats. Transplant Proc 2018; 49:1935-1941. [PMID: 28923651 DOI: 10.1016/j.transproceed.2017.06.028] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2017] [Accepted: 06/01/2017] [Indexed: 12/27/2022]
Abstract
PURPOSE To evaluate the potential of high-resolution magic angle spinning (HR-MAS) 1H nuclear magnetic resonance (NMR) spectroscopy for metabolite characterization and the differentiation of acute rejection after heart transplantation in rat models. METHODS We transplanted syngeneic heart grafts from Lewis rats (n = 4) and allogeneic heart grafts from F344 rats (n = 4) heterotopically into Lewis recipients. On day 7 postoperatively, the transplanted hearts were harvested for ex vivo 1H NMR spectroscopy and HR-MAS 1H NMR spectroscopy. 1H NMR spectroscopy and HR-MAS 1H NMR spectroscopy were performed at 4.7 T and 11.7 T, respectively. Metabolomic profiles contributing to the differentiation of allogeneic and syngeneic graft groups were statistically assessed by orthogonal partial least squares discriminant analysis (OPLS/O2PLS-DA). Metabolite concentrations were normalized by total spectral intensities and were compared using Mann-Whitney U tests. RESULTS One allogeneic graft that showed extensive necrotic change suggesting graft failure was excluded from the statistical analysis of the NMR spectroscopy. In the 4.7-T 1H NMR spectroscopy, the creatine peak was decreased in the allogeneic group. The PLS-DA and OPLS/O2PLS-DA score plot demonstrated good discrimination of the allogeneic graft group from syngeneic graft group. The concentrations of creatine, myo-inositol, glucose, niacinamide, hypoxanthine, inosine, and glutamine were significantly decreased in the allogeneic graft group, whereas the concentrations of glycine, phosphoethanolamine, xanthine, sn-glycero-3-phosphocholine, leucine, valine, and tyrosine were significantly increased (P < .05). CONCLUSIONS HR-MAS 1H NMR spectroscopy can metabolically characterize the acute rejection of heart transplantation.
Collapse
Affiliation(s)
- C W Lee
- Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea
| | - J S Lee
- Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
| | - C W Woo
- Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea
| | - S Kim
- Department of Chemistry, Center for Proteome Biophysics and Chemistry Institute for Functional Materials, Pusan National University, Busan, Republic of Korea
| |
Collapse
|
66
|
Choi YJ, Ock SY, Jin Y, Lee JS, Kim SH, Chung YS. Urinary Pentosidine levels negatively associates with trabecular bone scores in patients with type 2 diabetes mellitus. Osteoporos Int 2018; 29:907-915. [PMID: 29322222 DOI: 10.1007/s00198-017-4359-7] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/04/2017] [Accepted: 12/18/2017] [Indexed: 12/27/2022]
Abstract
UNLABELLED Pentosidine levels were higher in diabetic patients with vertebral fractures. Trabecular bone scores were negatively associated with pentosidine levels in diabetic patients only. Our results provide further evidence that AGEs are associated with the pathogenesis of bone fragility in patients with T2DM. INTRODUCTION Type 2 diabetes mellitus (T2DM) is associated with fracture risk. Pentosidine, an advanced glycation end product (AGE), is associated with prevalent vertebral fractures (VFs) in patients with T2DM. Trabecular bone score (TBS) has been proposed as an index of bone microarchitecture associated with bone quality. This study evaluated the associations of urine pentosidine and TBS in T2DM and non-T2DM groups. METHODS A total of 112 T2DM patients and 62 non-T2DM subjects were enrolled. TBS was calculated using TBS insight® software (version 2.1). Pentosidine levels were measured using high-performance liquid chromatography method. We compared the BMD, TBS, and pentosidine levels between those with and without VFs with or without adjustment for age and sex. The association with TBS, lumbar spine BMD, and pentosidine levels were also evaluated in both T2DM and non-T2DM groups. RESULTS Pentosidine levels were significantly higher in T2DM patients with VFs. TBSs were significantly lower in patients with T2DM and VFs. In non-diabetic patients, there were no significant differences in TBS and pentosidine levels for those with and without VFs after adjustment for age and sex. Pentosidine levels were negatively associated with TBS only in patients with T2DM. In multivariate stepwise regression analysis, pentosidine levels were significantly associated with TBS in patients with T2DM. CONCLUSIONS TBS and pentosidine could be used as a method to assess bone quality to identify T2DM patients at risk of VFs. Our results also provide further evidence that AGEs are associated with the pathogenesis of bone fragility in patients with T2DM.
Collapse
Affiliation(s)
- Y J Choi
- Department of Endocrinology and Metabolism, Ajou University School of Medicine, 164 World cup-ro, Suwon, 16499, South Korea
| | - S Y Ock
- Department of Endocrinology and Metabolism, Kosin University School of Medicine, Busan, South Korea
| | - Y Jin
- Department of Endocrinology and Metabolism, Ajou University School of Medicine, 164 World cup-ro, Suwon, 16499, South Korea
| | - J S Lee
- College of Pharmacy and Research Institute of Pharmaceutical Science and Technology, Ajou University, Suwon, South Korea
| | - S H Kim
- College of Pharmacy and Research Institute of Pharmaceutical Science and Technology, Ajou University, Suwon, South Korea
| | - Y -S Chung
- Department of Endocrinology and Metabolism, Ajou University School of Medicine, 164 World cup-ro, Suwon, 16499, South Korea.
| |
Collapse
|
67
|
Abstract
AIMS Adjuvant treatment after intralesional curettage for atypical cartilaginous tumours (ACTs) of long bones is widely accepted for extending surgical margins. However, evaluating the isolated effect of adjuvant treatment is difficult, and it is unclear whether not using such adjuvants provides poor oncological outcomes. Hence, we analyzed whether intralesional curettage without cryosurgery or chemical adjuvants provides poor oncological outcomes in patients with an ACT. PATIENTS AND METHODS A total of 24 patients (nine men, 15 women) (mean age 45 years; 18 to 62) were treated for ACTs of long bones and followed up for a median of 66 months (interquartile range 50 to 84). All patients were treated with extensive manual curettage and limited burring. Bone cement and grafts were used to fill bone defects in 16 and eight patients, respectively. No chemical adjuvants or cryosurgery were used. RESULTS No local recurrence was detectable on plain radiographs and MRI or CT images. At the last follow-up, there were no distant metastases or disease-specific deaths. No procedure-related complications or postoperative fractures developed. CONCLUSION Intralesional curettage without cryosurgery or chemical adjuvants may provide excellent oncological outcomes for patients with ACTs of long bones, without the risk of complications related to adjuvant use. Our investigation suggests thorough curettage alone is a reasonable treatment option for ACT. However, we acknowledge the limited size of our investigation warrants a multicentre collaborative study to confirm our findings. Cite this article: Bone Joint J 2018;100-B:256-61.
Collapse
Affiliation(s)
- W Kim
- Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, South Korea
| | - J S Lee
- Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, South Korea
| | - H W Chung
- Asan Medical Center, University of Ulsan College of Medicine , 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, South Korea
| |
Collapse
|
68
|
Aaltonen T, Abazov VM, Abbott B, Acharya BS, Adams M, Adams T, Agnew JP, Alexeev GD, Alkhazov G, Alton A, Amerio S, Amidei D, Anastassov A, Annovi A, Antos J, Apollinari G, Appel JA, Arisawa T, Artikov A, Asaadi J, Ashmanskas W, Askew A, Atkins S, Auerbach B, Augsten K, Aurisano A, Aushev V, Aushev Y, Avila C, Azfar F, Badaud F, Badgett W, Bae T, Bagby L, Baldin B, Bandurin DV, Banerjee S, Barbaro-Galtieri A, Barberis E, Baringer P, Barnes VE, Barnett BA, Barria P, Bartlett JF, Bartos P, Bassler U, Bauce M, Bazterra V, Bean A, Bedeschi F, Begalli M, Behari S, Bellantoni L, Bellettini G, Bellinger J, Benjamin D, Beretvas A, Beri SB, Bernardi G, Bernhard R, Bertram I, Besançon M, Beuselinck R, Bhat PC, Bhatia S, Bhatnagar V, Bhatti A, Bland KR, Blazey G, Blessing S, Bloom K, Blumenfeld B, Bocci A, Bodek A, Boehnlein A, Boline D, Boos EE, Borissov G, Bortoletto D, Borysova M, Boudreau J, Boveia A, Brandt A, Brandt O, Brigliadori L, Brochmann M, Brock R, Bromberg C, Bross A, Brown D, Brucken E, Bu XB, Budagov J, Budd HS, Buehler M, Buescher V, Bunichev V, Burdin S, Burkett K, Busetto G, Bussey P, Buszello CP, Butti P, Buzatu A, Calamba A, Camacho-Pérez E, Camarda S, Campanelli M, Canelli F, Carls B, Carlsmith D, Carosi R, Carrillo S, Casal B, Casarsa M, Casey BCK, Castilla-Valdez H, Castro A, Catastini P, Caughron S, Cauz D, Cavaliere V, Cerri A, Cerrito L, Chakrabarti S, Chan KM, Chandra A, Chapelain A, Chapon E, Chen G, Chen YC, Chertok M, Chiarelli G, Chlachidze G, Cho K, Cho SW, Choi S, Chokheli D, Choudhary B, Cihangir S, Claes D, Clark A, Clarke C, Clutter J, Convery ME, Conway J, Cooke M, Cooper WE, Corbo M, Corcoran M, Cordelli M, Couderc F, Cousinou MC, Cox CA, Cox DJ, Cremonesi M, Cruz D, Cuevas J, Culbertson R, Cuth J, Cutts D, Das A, d'Ascenzo N, Datta M, Davies G, de Barbaro P, de Jong SJ, De La Cruz-Burelo E, Déliot F, Demina R, Demortier L, Deninno M, Denisov D, Denisov SP, D'Errico M, Desai S, Deterre C, DeVaughan K, Devoto F, Di Canto A, Di Ruzza B, Diehl HT, Diesburg M, Ding PF, Dittmann JR, Dominguez A, Donati S, D'Onofrio M, Dorigo M, Driutti A, Drutskoy A, Dubey A, Dudko LV, Duperrin A, Dutt S, Eads M, Ebina K, Edgar R, Edmunds D, Elagin A, Ellison J, Elvira VD, Enari Y, Erbacher R, Errede S, Esham B, Evans H, Evdokimov A, Evdokimov VN, Farrington S, Fauré A, Feng L, Ferbel T, Fernández Ramos JP, Fiedler F, Field R, Filthaut F, Fisher W, Fisk HE, Flanagan G, Forrest R, Fortner M, Fox H, Franc J, Franklin M, Freeman JC, Frisch H, Fuess S, Funakoshi Y, Galloni C, Garbincius PH, Garcia-Bellido A, García-González JA, Garfinkel AF, Garosi P, Gavrilov V, Geng W, Gerber CE, Gerberich H, Gerchtein E, Gershtein Y, Giagu S, Giakoumopoulou V, Gibson K, Ginsburg CM, Ginther G, Giokaris N, Giromini P, Glagolev V, Glenzinski D, Gogota O, Gold M, Goldin D, Golossanov A, Golovanov G, Gomez G, Gomez-Ceballos G, Goncharov M, González López O, Gorelov I, Goshaw AT, Goulianos K, Gramellini E, Grannis PD, Greder S, Greenlee H, Grenier G, Gris P, Grivaz JF, Grohsjean A, Grosso-Pilcher C, Grünendahl S, Grünewald MW, Guillemin T, Guimaraes da Costa J, Gutierrez G, Gutierrez P, Hahn SR, Haley J, Han JY, Han L, Happacher F, Hara K, Harder K, Hare M, Harel A, Harr RF, Harrington-Taber T, Hatakeyama K, Hauptman JM, Hays C, Hays J, Head T, Hebbeker T, Hedin D, Hegab H, Heinrich J, Heinson AP, Heintz U, Hensel C, Heredia-De La Cruz I, Herndon M, Herner K, Hesketh G, Hildreth MD, Hirosky R, Hoang T, Hobbs JD, Hocker A, Hoeneisen B, Hogan J, Hohlfeld M, Holzbauer JL, Hong Z, Hopkins W, Hou S, Howley I, Hubacek Z, Hughes RE, Husemann U, Hussein M, Huston J, Hynek V, Iashvili I, Ilchenko Y, Illingworth R, Introzzi G, Iori M, Ito AS, Ivanov A, Jabeen S, Jaffré M, James E, Jang D, Jayasinghe A, Jayatilaka B, Jeon EJ, Jeong MS, Jesik R, Jiang P, Jindariani S, Johns K, Johnson E, Johnson M, Jonckheere A, Jones M, Jonsson P, Joo KK, Joshi J, Jun SY, Jung AW, Junk TR, Juste A, Kajfasz E, Kambeitz M, Kamon T, Karchin PE, Karmanov D, Kasmi A, Kato Y, Katsanos I, Kaur M, Kehoe R, Kermiche S, Ketchum W, Keung J, Khalatyan N, Khanov A, Kharchilava A, Kharzheev YN, Kilminster B, Kim DH, Kim HS, Kim JE, Kim MJ, Kim SH, Kim SB, Kim YJ, Kim YK, Kimura N, Kirby M, Kiselevich I, Kohli JM, Kondo K, Kong DJ, Konigsberg J, Kotwal AV, Kozelov AV, Kraus J, Kreps M, Kroll J, Kruse M, Kuhr T, Kumar A, Kupco A, Kurata M, Kurča T, Kuzmin VA, Laasanen AT, Lammel S, Lammers S, Lancaster M, Lannon K, Latino G, Lebrun P, Lee HS, Lee HS, Lee JS, Lee SW, Lee WM, Lei X, Lellouch J, Leo S, Leone S, Lewis JD, Li D, Li H, Li L, Li QZ, Lim JK, Limosani A, Lincoln D, Linnemann J, Lipaev VV, Lipeles E, Lipton R, Lister A, Liu H, Liu Q, Liu T, Liu Y, Lobodenko A, Lockwitz S, Loginov A, Lokajicek M, Lopes de Sa R, Lucchesi D, Lucà A, Lueck J, Lujan P, Lukens P, Luna-Garcia R, Lungu G, Lyon AL, Lys J, Lysak R, Maciel AKA, Madar R, Madrak R, Maestro P, Magaña-Villalba R, Malik S, Malik S, Malyshev VL, Manca G, Manousakis-Katsikakis A, Mansour J, Marchese L, Margaroli F, Marino P, Martínez-Ortega J, Matera K, Mattson ME, Mazzacane A, Mazzanti P, McCarthy R, McGivern CL, McNulty R, Mehta A, Mehtala P, Meijer MM, Melnitchouk A, Menezes D, Mercadante PG, Merkin M, Mesropian C, Meyer A, Meyer J, Miao T, Miconi F, Mietlicki D, Mitra A, Miyake H, Moed S, Moggi N, Mondal NK, Moon CS, Moore R, Morello MJ, Mukherjee A, Mulhearn M, Muller T, Murat P, Mussini M, Nachtman J, Nagai Y, Naganoma J, Nagy E, Nakano I, Napier A, Narain M, Nayyar R, Neal HA, Negret JP, Nett J, Neustroev P, Nguyen HT, Nigmanov T, Nodulman L, Noh SY, Norniella O, Nunnemann T, Oakes L, Oh SH, Oh YD, Okusawa T, Orava R, Orduna J, Ortolan L, Osman N, Pagliarone C, Pal A, Palencia E, Palni P, Papadimitriou V, Parashar N, Parihar V, Park SK, Parker W, Partridge R, Parua N, Patwa A, Pauletta G, Paulini M, Paus C, Penning B, Perfilov M, Peters Y, Petridis K, Petrillo G, Pétroff P, Phillips TJ, Piacentino G, Pianori E, Pilot J, Pitts K, Plager C, Pleier MA, Podstavkov VM, Pondrom L, Popov AV, Poprocki S, Potamianos K, Pranko A, Prewitt M, Price D, Prokopenko N, Prokoshin F, Ptohos F, Punzi G, Qian J, Quadt A, Quinn B, Ratoff PN, Razumov I, Redondo Fernández I, Renton P, Rescigno M, Rimondi F, Ripp-Baudot I, Ristori L, Rizatdinova F, Robson A, Rodriguez T, Rolli S, Rominsky M, Ronzani M, Roser R, Rosner JL, Ross A, Royon C, Rubinov P, Ruchti R, Ruffini F, Ruiz A, Russ J, Rusu V, Sajot G, Sakumoto WK, Sakurai Y, Sánchez-Hernández A, Sanders MP, Santi L, Santos AS, Sato K, Savage G, Saveliev V, Savitskyi M, Savoy-Navarro A, Sawyer L, Scanlon T, Schamberger RD, Scheglov Y, Schellman H, Schlabach P, Schmidt EE, Schott M, Schwanenberger C, Schwarz T, Schwienhorst R, Scodellaro L, Scuri F, Seidel S, Seiya Y, Sekaric J, Semenov A, Severini H, Sforza F, Shabalina E, Shalhout SZ, Shary V, Shaw S, Shchukin AA, Shears T, Shepard PF, Shimojima M, Shkola O, Shochet M, Shreyber-Tecker I, Simak V, Simonenko A, Skubic P, Slattery P, Sliwa K, Smith JR, Snider FD, Snow GR, Snow J, Snyder S, Söldner-Rembold S, Song H, Sonnenschein L, Sorin V, Soustruznik K, St Denis R, Stancari M, Stark J, Stefaniuk N, Stentz D, Stoyanova DA, Strauss M, Strologas J, Sudo Y, Sukhanov A, Suslov I, Suter L, Svoisky P, Takemasa K, Takeuchi Y, Tang J, Tecchio M, Teng PK, Thom J, Thomson E, Thukral V, Titov M, Toback D, Tokar S, Tokmenin VV, Tollefson K, Tomura T, Tonelli D, Torre S, Torretta D, Totaro P, Trovato M, Tsai YT, Tsybychev D, Tuchming B, Tully C, Ukegawa F, Uozumi S, Uvarov L, Uvarov S, Uzunyan S, Van Kooten R, van Leeuwen WM, Varelas N, Varnes EW, Vasilyev IA, Vázquez F, Velev G, Vellidis C, Verkheev AY, Vernieri C, Vertogradov LS, Verzocchi M, Vesterinen M, Vidal M, Vilanova D, Vilar R, Vizán J, Vogel M, Vokac P, Volpi G, Wagner P, Wahl HD, Wallny R, Wang MHLS, Wang SM, Warchol J, Waters D, Watts G, Wayne M, Weichert J, Welty-Rieger L, Wester WC, Whiteson D, Wicklund AB, Wilbur S, Williams HH, Williams MRJ, Wilson GW, Wilson JS, Wilson P, Winer BL, Wittich P, Wobisch M, Wolbers S, Wolfmeister H, Wood DR, Wright T, Wu X, Wu Z, Wyatt TR, Xie Y, Yamada R, Yamamoto K, Yamato D, Yang S, Yang T, Yang UK, Yang YC, Yao WM, Yasuda T, Yatsunenko YA, Ye W, Ye Z, Yeh GP, Yi K, Yin H, Yip K, Yoh J, Yorita K, Yoshida T, Youn SW, Yu GB, Yu I, Yu JM, Zanetti AM, Zeng Y, Zennamo J, Zhao TG, Zhou B, Zhou C, Zhu J, Zielinski M, Zieminska D, Zivkovic L, Zucchelli S. Combined Forward-Backward Asymmetry Measurements in Top-Antitop Quark Production at the Tevatron. Phys Rev Lett 2018; 120:042001. [PMID: 29437406 DOI: 10.1103/physrevlett.120.042001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/13/2017] [Indexed: 06/08/2023]
Abstract
The CDF and D0 experiments at the Fermilab Tevatron have measured the asymmetry between yields of forward- and backward-produced top and antitop quarks based on their rapidity difference and the asymmetry between their decay leptons. These measurements use the full data sets collected in proton-antiproton collisions at a center-of-mass energy of sqrt[s]=1.96 TeV. We report the results of combinations of the inclusive asymmetries and their differential dependencies on relevant kinematic quantities. The combined inclusive asymmetry is A_{FB}^{tt[over ¯]}=0.128±0.025. The combined inclusive and differential asymmetries are consistent with recent standard model predictions.
Collapse
Affiliation(s)
- T Aaltonen
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - V M Abazov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - B Abbott
- University of Oklahoma, Norman, Oklahoma 73019, USA
| | - B S Acharya
- Tata Institute of Fundamental Research, Mumbai-400 005, India
| | - M Adams
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - T Adams
- Florida State University, Tallahassee, Florida 32306, USA
| | - J P Agnew
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - G D Alexeev
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - G Alkhazov
- Petersburg Nuclear Physics Institute, St. Petersburg 188300, Russia
| | - A Alton
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - S Amerio
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - D Amidei
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - A Anastassov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Annovi
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - J Antos
- Comenius University, 842 48 Bratislava, Slovakia; Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - G Apollinari
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J A Appel
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | - A Artikov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - J Asaadi
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - W Ashmanskas
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Askew
- Florida State University, Tallahassee, Florida 32306, USA
| | - S Atkins
- Louisiana Tech University, Ruston, Louisiana 71272, USA
| | - B Auerbach
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - K Augsten
- Czech Technical University in Prague, 116 36 Prague 6, Czech Republic
| | - A Aurisano
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - V Aushev
- Taras Shevchenko National University of Kyiv, Kiev 01601, Ukraine
| | - Y Aushev
- Taras Shevchenko National University of Kyiv, Kiev 01601, Ukraine
| | - C Avila
- Universidad de los Andes, Bogotá 111711, Colombia
| | - F Azfar
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - F Badaud
- LPC, Université Blaise Pascal, CNRS/IN2P3, Clermont, F-63178 Aubière Cedex, France
| | - W Badgett
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - T Bae
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - L Bagby
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - B Baldin
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D V Bandurin
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - S Banerjee
- Tata Institute of Fundamental Research, Mumbai-400 005, India
| | - A Barbaro-Galtieri
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - E Barberis
- Northeastern University, Boston, Massachusetts 02115, USA
| | - P Baringer
- University of Kansas, Lawrence, Kansas 66045, USA
| | - V E Barnes
- Purdue University, West Lafayette, Indiana 47907, USA
| | - B A Barnett
- The Johns Hopkins University, Baltimore, Maryland 21218, USA
| | - P Barria
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | - J F Bartlett
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Bartos
- Comenius University, 842 48 Bratislava, Slovakia; Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - U Bassler
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - M Bauce
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - V Bazterra
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - A Bean
- University of Kansas, Lawrence, Kansas 66045, USA
| | - F Bedeschi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - M Begalli
- Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ 20550, Brazil
| | - S Behari
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - L Bellantoni
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Bellettini
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - J Bellinger
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - D Benjamin
- Duke University, Durham, North Carolina 27708, USA
| | - A Beretvas
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S B Beri
- Panjab University, Chandigarh 160014, India
| | - G Bernardi
- LPNHE, Universités Paris VI and VII, CNRS/IN2P3, F-75005 Paris, France
| | - R Bernhard
- Physikalisches Institut, Universität Freiburg, 79085 Freiburg, Germany
| | - I Bertram
- Lancaster University, Lancaster LA1 4YB, United Kingdom
| | - M Besançon
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - R Beuselinck
- Imperial College London, London SW7 2AZ, United Kingdom
| | - P C Bhat
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Bhatia
- University of Mississippi, University, Mississippi 38677, USA
| | | | - A Bhatti
- The Rockefeller University, New York, New York 10065, USA
| | - K R Bland
- Baylor University, Waco, Texas 76798, USA
| | - G Blazey
- Northern Illinois University, DeKalb, Illinois 60115, USA
| | - S Blessing
- Florida State University, Tallahassee, Florida 32306, USA
| | - K Bloom
- University of Nebraska, Lincoln, Nebraska 68588, USA
| | - B Blumenfeld
- The Johns Hopkins University, Baltimore, Maryland 21218, USA
| | - A Bocci
- Duke University, Durham, North Carolina 27708, USA
| | - A Bodek
- University of Rochester, Rochester, New York 14627, USA
| | - A Boehnlein
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Boline
- State University of New York, Stony Brook, New York 11794, USA
| | - E E Boos
- Moscow State University, Moscow 119991, Russia
| | - G Borissov
- Lancaster University, Lancaster LA1 4YB, United Kingdom
| | - D Bortoletto
- Purdue University, West Lafayette, Indiana 47907, USA
| | - M Borysova
- Taras Shevchenko National University of Kyiv, Kiev 01601, Ukraine
| | - J Boudreau
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - A Boveia
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - A Brandt
- University of Texas, Arlington, Texas 76019, USA
| | - O Brandt
- II. Physikalisches Institut, Georg-August-Universität Göttingen, 37073 Göttingen, Germany
| | - L Brigliadori
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
- University of Bologna, I-40127 Bologna, Italy
| | - M Brochmann
- University of Washington, Seattle, Washington 98195, USA
| | - R Brock
- Michigan State University, East Lansing, Michigan 48824, USA
| | - C Bromberg
- Michigan State University, East Lansing, Michigan 48824, USA
| | - A Bross
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Brown
- LPNHE, Universités Paris VI and VII, CNRS/IN2P3, F-75005 Paris, France
| | - E Brucken
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - X B Bu
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Budagov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - H S Budd
- University of Rochester, Rochester, New York 14627, USA
| | - M Buehler
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - V Buescher
- Institut für Physik, Universität Mainz, 55099 Mainz, Germany
| | - V Bunichev
- Moscow State University, Moscow 119991, Russia
| | - S Burdin
- Lancaster University, Lancaster LA1 4YB, United Kingdom
| | - K Burkett
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Busetto
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - P Bussey
- Glasgow University, Glasgow G12 8QQ, United Kingdom
| | | | - P Butti
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - A Buzatu
- Glasgow University, Glasgow G12 8QQ, United Kingdom
| | - A Calamba
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | | | - S Camarda
- Institut de Fisica d'Altes Energies, ICREA, Universitat Autonoma de Barcelona, E-08193, Bellaterra (Barcelona), Spain
| | - M Campanelli
- University College London, London WC1E 6BT, United Kingdom
| | - F Canelli
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - B Carls
- University of Illinois, Urbana, Illinois 61801, USA
| | - D Carlsmith
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - R Carosi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - S Carrillo
- University of Florida, Gainesville, Florida 32611, USA
| | - B Casal
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - M Casarsa
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
| | - B C K Casey
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | - A Castro
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
- University of Bologna, I-40127 Bologna, Italy
| | - P Catastini
- Harvard University, Cambridge, Massachusetts 02138, USA
| | - S Caughron
- Michigan State University, East Lansing, Michigan 48824, USA
| | - D Cauz
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- Gruppo Collegato di Udine, I-33100 Udine, Italy
- University of Udine, I-33100 Udine, Italy
| | - V Cavaliere
- University of Illinois, Urbana, Illinois 61801, USA
| | - A Cerri
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - L Cerrito
- University College London, London WC1E 6BT, United Kingdom
| | - S Chakrabarti
- State University of New York, Stony Brook, New York 11794, USA
| | - K M Chan
- University of Notre Dame, Notre Dame, Indiana 46556, USA
| | - A Chandra
- Rice University, Houston, Texas 77005, USA
| | - A Chapelain
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - E Chapon
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - G Chen
- University of Kansas, Lawrence, Kansas 66045, USA
| | - Y C Chen
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - M Chertok
- University of California, Davis, Davis, California 95616, USA
| | - G Chiarelli
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - G Chlachidze
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Cho
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - S W Cho
- Korea Detector Laboratory, Korea University, Seoul 02841, Korea
| | - S Choi
- Korea Detector Laboratory, Korea University, Seoul 02841, Korea
| | - D Chokheli
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | | | - S Cihangir
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Claes
- University of Nebraska, Lincoln, Nebraska 68588, USA
| | - A Clark
- University of Geneva, CH-1211 Geneva 4, Switzerland
| | - C Clarke
- Wayne State University, Detroit, Michigan 48201, USA
| | - J Clutter
- University of Kansas, Lawrence, Kansas 66045, USA
| | - M E Convery
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Conway
- University of California, Davis, Davis, California 95616, USA
| | - M Cooke
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - W E Cooper
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Corbo
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Corcoran
- Rice University, Houston, Texas 77005, USA
| | - M Cordelli
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - F Couderc
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - M-C Cousinou
- CPPM, Aix-Marseille Université, CNRS/IN2P3, F-13288 Marseille Cedex 09, France
| | - C A Cox
- University of California, Davis, Davis, California 95616, USA
| | - D J Cox
- University of California, Davis, Davis, California 95616, USA
| | - M Cremonesi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - D Cruz
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - J Cuevas
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - R Culbertson
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Cuth
- Institut für Physik, Universität Mainz, 55099 Mainz, Germany
| | - D Cutts
- Brown University, Providence, Rhode Island 02912, USA
| | - A Das
- Southern Methodist University, Dallas, Texas 75275, USA
| | - N d'Ascenzo
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Datta
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Davies
- Imperial College London, London SW7 2AZ, United Kingdom
| | - P de Barbaro
- University of Rochester, Rochester, New York 14627, USA
| | - S J de Jong
- Nikhef, Science Park, 1098 XG Amsterdam, The Netherlands
- Radboud University Nijmegen, 6525 AJ Nijmegen, The Netherlands
| | | | - F Déliot
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - R Demina
- University of Rochester, Rochester, New York 14627, USA
| | - L Demortier
- The Rockefeller University, New York, New York 10065, USA
| | - M Deninno
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - D Denisov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S P Denisov
- Institute for High Energy Physics, Protvino, Moscow region 142281, Russia
| | - M D'Errico
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - S Desai
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - C Deterre
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - K DeVaughan
- University of Nebraska, Lincoln, Nebraska 68588, USA
| | - F Devoto
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - A Di Canto
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - B Di Ruzza
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - H T Diehl
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Diesburg
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P F Ding
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | | | - A Dominguez
- University of Nebraska, Lincoln, Nebraska 68588, USA
| | - S Donati
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - M D'Onofrio
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - M Dorigo
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- University of Trieste, I-34127 Trieste, Italy
| | - A Driutti
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- Gruppo Collegato di Udine, I-33100 Udine, Italy
- University of Udine, I-33100 Udine, Italy
| | - A Drutskoy
- Institute for Theoretical and Experimental Physics, ITEP, Moscow 117259, Russia
| | - A Dubey
- Delhi University, Delhi-110 007, India
| | - L V Dudko
- Moscow State University, Moscow 119991, Russia
| | - A Duperrin
- CPPM, Aix-Marseille Université, CNRS/IN2P3, F-13288 Marseille Cedex 09, France
| | - S Dutt
- Panjab University, Chandigarh 160014, India
| | - M Eads
- Northern Illinois University, DeKalb, Illinois 60115, USA
| | - K Ebina
- Waseda University, Tokyo 169, Japan
| | - R Edgar
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - D Edmunds
- Michigan State University, East Lansing, Michigan 48824, USA
| | - A Elagin
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - J Ellison
- University of California Riverside, Riverside, California 92521, USA
| | - V D Elvira
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Y Enari
- LPNHE, Universités Paris VI and VII, CNRS/IN2P3, F-75005 Paris, France
| | - R Erbacher
- University of California, Davis, Davis, California 95616, USA
| | - S Errede
- University of Illinois, Urbana, Illinois 61801, USA
| | - B Esham
- University of Illinois, Urbana, Illinois 61801, USA
| | - H Evans
- Indiana University, Bloomington, Indiana 47405, USA
| | - A Evdokimov
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - V N Evdokimov
- Institute for High Energy Physics, Protvino, Moscow region 142281, Russia
| | - S Farrington
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - A Fauré
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - L Feng
- Northern Illinois University, DeKalb, Illinois 60115, USA
| | - T Ferbel
- University of Rochester, Rochester, New York 14627, USA
| | - J P Fernández Ramos
- Centro de Investigaciones Energeticas Medioambientales y Tecnologicas, E-28040 Madrid, Spain
| | - F Fiedler
- Institut für Physik, Universität Mainz, 55099 Mainz, Germany
| | - R Field
- University of Florida, Gainesville, Florida 32611, USA
| | - F Filthaut
- Nikhef, Science Park, 1098 XG Amsterdam, The Netherlands
- Radboud University Nijmegen, 6525 AJ Nijmegen, The Netherlands
| | - W Fisher
- Michigan State University, East Lansing, Michigan 48824, USA
| | - H E Fisk
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Flanagan
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Forrest
- University of California, Davis, Davis, California 95616, USA
| | - M Fortner
- Northern Illinois University, DeKalb, Illinois 60115, USA
| | - H Fox
- Lancaster University, Lancaster LA1 4YB, United Kingdom
| | - J Franc
- Czech Technical University in Prague, 116 36 Prague 6, Czech Republic
| | - M Franklin
- Harvard University, Cambridge, Massachusetts 02138, USA
| | - J C Freeman
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - H Frisch
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - S Fuess
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | - C Galloni
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - P H Garbincius
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | | | - A F Garfinkel
- Purdue University, West Lafayette, Indiana 47907, USA
| | - P Garosi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | - V Gavrilov
- Institute for Theoretical and Experimental Physics, ITEP, Moscow 117259, Russia
| | - W Geng
- Michigan State University, East Lansing, Michigan 48824, USA
- CPPM, Aix-Marseille Université, CNRS/IN2P3, F-13288 Marseille Cedex 09, France
| | - C E Gerber
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - H Gerberich
- University of Illinois, Urbana, Illinois 61801, USA
| | - E Gerchtein
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Y Gershtein
- Rutgers University, Piscataway, New Jersey 08855, USA
| | - S Giagu
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
| | | | - K Gibson
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - C M Ginsburg
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Ginther
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - N Giokaris
- University of Athens, 157 71 Athens, Greece
| | - P Giromini
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - V Glagolev
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - D Glenzinski
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - O Gogota
- Taras Shevchenko National University of Kyiv, Kiev 01601, Ukraine
| | - M Gold
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - D Goldin
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - A Golossanov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Golovanov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - G Gomez
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - G Gomez-Ceballos
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - M Goncharov
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - O González López
- Centro de Investigaciones Energeticas Medioambientales y Tecnologicas, E-28040 Madrid, Spain
| | - I Gorelov
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - A T Goshaw
- Duke University, Durham, North Carolina 27708, USA
| | - K Goulianos
- The Rockefeller University, New York, New York 10065, USA
| | - E Gramellini
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - P D Grannis
- State University of New York, Stony Brook, New York 11794, USA
| | - S Greder
- IPHC, Université de Strasbourg, CNRS/IN2P3, F-67037 Strasbourg, France
| | - H Greenlee
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Grenier
- IPNL, Université Lyon 1, CNRS/IN2P3, F-69622 Villeurbanne Cedex, France and Université de Lyon, F-69361 Lyon CEDEX 07, France
| | - Ph Gris
- LPC, Université Blaise Pascal, CNRS/IN2P3, Clermont, F-63178 Aubière Cedex, France
| | - J-F Grivaz
- LAL, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91898 Orsay Cedex, France
| | - A Grohsjean
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - C Grosso-Pilcher
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - S Grünendahl
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | - T Guillemin
- LAL, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91898 Orsay Cedex, France
| | | | - G Gutierrez
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Gutierrez
- University of Oklahoma, Norman, Oklahoma 73019, USA
| | - S R Hahn
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Haley
- Oklahoma State University, Stillwater, Oklahoma 74078, USA
| | - J Y Han
- University of Rochester, Rochester, New York 14627, USA
| | - L Han
- University of Science and Technology of China, Hefei 230026, People's Republic of China
| | - F Happacher
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - K Hara
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - K Harder
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - M Hare
- Tufts University, Medford, Massachusetts 02155, USA
| | - A Harel
- University of Rochester, Rochester, New York 14627, USA
| | - R F Harr
- Wayne State University, Detroit, Michigan 48201, USA
| | | | | | | | - C Hays
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - J Hays
- Imperial College London, London SW7 2AZ, United Kingdom
| | - T Head
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - T Hebbeker
- III. Physikalisches Institut A, RWTH Aachen University, 52056 Aachen, Germany
| | - D Hedin
- Northern Illinois University, DeKalb, Illinois 60115, USA
| | - H Hegab
- Oklahoma State University, Stillwater, Oklahoma 74078, USA
| | - J Heinrich
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - A P Heinson
- University of California Riverside, Riverside, California 92521, USA
| | - U Heintz
- Brown University, Providence, Rhode Island 02912, USA
| | - C Hensel
- LAFEX, Centro Brasileiro de Pesquisas Físicas, Rio de Janeiro, RJ 22290, Brazil
| | | | - M Herndon
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - K Herner
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Hesketh
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - M D Hildreth
- University of Notre Dame, Notre Dame, Indiana 46556, USA
| | - R Hirosky
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - T Hoang
- Florida State University, Tallahassee, Florida 32306, USA
| | - J D Hobbs
- State University of New York, Stony Brook, New York 11794, USA
| | - A Hocker
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - B Hoeneisen
- Universidad San Francisco de Quito, Quito 170157, Ecuador
| | - J Hogan
- Rice University, Houston, Texas 77005, USA
| | - M Hohlfeld
- Institut für Physik, Universität Mainz, 55099 Mainz, Germany
| | - J L Holzbauer
- University of Mississippi, University, Mississippi 38677, USA
| | - Z Hong
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - W Hopkins
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Hou
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - I Howley
- University of Texas, Arlington, Texas 76019, USA
| | - Z Hubacek
- Czech Technical University in Prague, 116 36 Prague 6, Czech Republic
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - R E Hughes
- The Ohio State University, Columbus, Ohio 43210, USA
| | - U Husemann
- Yale University, New Haven, Connecticut 06520, USA
| | - M Hussein
- Michigan State University, East Lansing, Michigan 48824, USA
| | - J Huston
- Michigan State University, East Lansing, Michigan 48824, USA
| | - V Hynek
- Czech Technical University in Prague, 116 36 Prague 6, Czech Republic
| | - I Iashvili
- State University of New York, Buffalo, New York 14260, USA
| | - Y Ilchenko
- Southern Methodist University, Dallas, Texas 75275, USA
| | - R Illingworth
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Introzzi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- INFN Pavia, I-27100 Pavia, Italy
- University of Pavia, I-27100 Pavia, Italy
| | - M Iori
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
- Sapienza Università di Roma, I-00185 Roma, Italy
| | - A S Ito
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Ivanov
- University of California, Davis, Davis, California 95616, USA
| | - S Jabeen
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Jaffré
- LAL, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91898 Orsay Cedex, France
| | - E James
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Jang
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - A Jayasinghe
- University of Oklahoma, Norman, Oklahoma 73019, USA
| | - B Jayatilaka
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - E J Jeon
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - M S Jeong
- Korea Detector Laboratory, Korea University, Seoul 02841, Korea
| | - R Jesik
- Imperial College London, London SW7 2AZ, United Kingdom
| | - P Jiang
- University of Science and Technology of China, Hefei 230026, People's Republic of China
| | - S Jindariani
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Johns
- University of Arizona, Tucson, Arizona 85721, USA
| | - E Johnson
- Michigan State University, East Lansing, Michigan 48824, USA
| | - M Johnson
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Jonckheere
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Jones
- Purdue University, West Lafayette, Indiana 47907, USA
| | - P Jonsson
- Imperial College London, London SW7 2AZ, United Kingdom
| | - K K Joo
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - J Joshi
- University of California Riverside, Riverside, California 92521, USA
| | - S Y Jun
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - A W Jung
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - T R Junk
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Juste
- Institució Catalana de Recerca i Estudis Avançats (ICREA) and Institut de Física d'Altes Energies (IFAE), 08193 Bellaterra (Barcelona), Spain
| | - E Kajfasz
- CPPM, Aix-Marseille Université, CNRS/IN2P3, F-13288 Marseille Cedex 09, France
| | - M Kambeitz
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - T Kamon
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - P E Karchin
- Wayne State University, Detroit, Michigan 48201, USA
| | - D Karmanov
- Moscow State University, Moscow 119991, Russia
| | - A Kasmi
- Baylor University, Waco, Texas 76798, USA
| | - Y Kato
- Osaka City University, Osaka 558-8585, Japan
| | - I Katsanos
- University of Nebraska, Lincoln, Nebraska 68588, USA
| | - M Kaur
- Panjab University, Chandigarh 160014, India
| | - R Kehoe
- Southern Methodist University, Dallas, Texas 75275, USA
| | - S Kermiche
- CPPM, Aix-Marseille Université, CNRS/IN2P3, F-13288 Marseille Cedex 09, France
| | - W Ketchum
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - J Keung
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - N Khalatyan
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Khanov
- Oklahoma State University, Stillwater, Oklahoma 74078, USA
| | - A Kharchilava
- State University of New York, Buffalo, New York 14260, USA
| | - Y N Kharzheev
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - B Kilminster
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D H Kim
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - H S Kim
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J E Kim
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - M J Kim
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - S H Kim
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - S B Kim
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - Y J Kim
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - Y K Kim
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - N Kimura
- Waseda University, Tokyo 169, Japan
| | - M Kirby
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - I Kiselevich
- Institute for Theoretical and Experimental Physics, ITEP, Moscow 117259, Russia
| | - J M Kohli
- Panjab University, Chandigarh 160014, India
| | - K Kondo
- Waseda University, Tokyo 169, Japan
| | - D J Kong
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - J Konigsberg
- University of Florida, Gainesville, Florida 32611, USA
| | - A V Kotwal
- Duke University, Durham, North Carolina 27708, USA
| | - A V Kozelov
- Institute for High Energy Physics, Protvino, Moscow region 142281, Russia
| | - J Kraus
- University of Mississippi, University, Mississippi 38677, USA
| | - M Kreps
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - J Kroll
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - M Kruse
- Duke University, Durham, North Carolina 27708, USA
| | - T Kuhr
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - A Kumar
- State University of New York, Buffalo, New York 14260, USA
| | - A Kupco
- Institute of Physics, Academy of Sciences of the Czech Republic, 182 21 Prague, Czech Republic
| | - M Kurata
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - T Kurča
- IPNL, Université Lyon 1, CNRS/IN2P3, F-69622 Villeurbanne Cedex, France and Université de Lyon, F-69361 Lyon CEDEX 07, France
| | - V A Kuzmin
- Moscow State University, Moscow 119991, Russia
| | - A T Laasanen
- Purdue University, West Lafayette, Indiana 47907, USA
| | - S Lammel
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Lammers
- Indiana University, Bloomington, Indiana 47405, USA
| | - M Lancaster
- University College London, London WC1E 6BT, United Kingdom
| | - K Lannon
- The Ohio State University, Columbus, Ohio 43210, USA
| | - G Latino
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | - P Lebrun
- IPNL, Université Lyon 1, CNRS/IN2P3, F-69622 Villeurbanne Cedex, France and Université de Lyon, F-69361 Lyon CEDEX 07, France
| | - H S Lee
- Korea Detector Laboratory, Korea University, Seoul 02841, Korea
| | - H S Lee
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - J S Lee
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - S W Lee
- Iowa State University, Ames, Iowa 50011, USA
| | - W M Lee
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - X Lei
- University of Arizona, Tucson, Arizona 85721, USA
| | - J Lellouch
- LPNHE, Universités Paris VI and VII, CNRS/IN2P3, F-75005 Paris, France
| | - S Leo
- University of Illinois, Urbana, Illinois 61801, USA
| | - S Leone
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - J D Lewis
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Li
- LPNHE, Universités Paris VI and VII, CNRS/IN2P3, F-75005 Paris, France
| | - H Li
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - L Li
- University of California Riverside, Riverside, California 92521, USA
| | - Q Z Li
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J K Lim
- Korea Detector Laboratory, Korea University, Seoul 02841, Korea
| | - A Limosani
- Duke University, Durham, North Carolina 27708, USA
| | - D Lincoln
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Linnemann
- Michigan State University, East Lansing, Michigan 48824, USA
| | - V V Lipaev
- Institute for High Energy Physics, Protvino, Moscow region 142281, Russia
| | - E Lipeles
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - R Lipton
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Lister
- University of Geneva, CH-1211 Geneva 4, Switzerland
| | - H Liu
- Southern Methodist University, Dallas, Texas 75275, USA
| | - Q Liu
- Purdue University, West Lafayette, Indiana 47907, USA
| | - T Liu
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Y Liu
- University of Science and Technology of China, Hefei 230026, People's Republic of China
| | - A Lobodenko
- Petersburg Nuclear Physics Institute, St. Petersburg 188300, Russia
| | - S Lockwitz
- Yale University, New Haven, Connecticut 06520, USA
| | - A Loginov
- Yale University, New Haven, Connecticut 06520, USA
| | - M Lokajicek
- Institute of Physics, Academy of Sciences of the Czech Republic, 182 21 Prague, Czech Republic
| | - R Lopes de Sa
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Lucchesi
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- University of Padova, I-35131 Padova, Italy
| | - A Lucà
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - J Lueck
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - P Lujan
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - P Lukens
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | - G Lungu
- The Rockefeller University, New York, New York 10065, USA
| | - A L Lyon
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Lys
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - R Lysak
- Comenius University, 842 48 Bratislava, Slovakia; Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - A K A Maciel
- LAFEX, Centro Brasileiro de Pesquisas Físicas, Rio de Janeiro, RJ 22290, Brazil
| | - R Madar
- Physikalisches Institut, Universität Freiburg, 79085 Freiburg, Germany
| | - R Madrak
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Maestro
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | | | - S Malik
- The Rockefeller University, New York, New York 10065, USA
| | - S Malik
- University of Nebraska, Lincoln, Nebraska 68588, USA
| | - V L Malyshev
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - G Manca
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | | | - J Mansour
- II. Physikalisches Institut, Georg-August-Universität Göttingen, 37073 Göttingen, Germany
| | - L Marchese
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - F Margaroli
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
| | - P Marino
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- Scuola Normale Superiore, I-56127 Pisa, Italy
| | | | - K Matera
- University of Illinois, Urbana, Illinois 61801, USA
| | - M E Mattson
- Wayne State University, Detroit, Michigan 48201, USA
| | - A Mazzacane
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Mazzanti
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - R McCarthy
- State University of New York, Stony Brook, New York 11794, USA
| | - C L McGivern
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - R McNulty
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - A Mehta
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - P Mehtala
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - M M Meijer
- Nikhef, Science Park, 1098 XG Amsterdam, The Netherlands
- Radboud University Nijmegen, 6525 AJ Nijmegen, The Netherlands
| | - A Melnitchouk
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Menezes
- Northern Illinois University, DeKalb, Illinois 60115, USA
| | - P G Mercadante
- Universidade Federal do ABC, Santo André, São Paulo, SP 09210, Brazil
| | - M Merkin
- Moscow State University, Moscow 119991, Russia
| | - C Mesropian
- The Rockefeller University, New York, New York 10065, USA
| | - A Meyer
- III. Physikalisches Institut A, RWTH Aachen University, 52056 Aachen, Germany
| | - J Meyer
- II. Physikalisches Institut, Georg-August-Universität Göttingen, 37073 Göttingen, Germany
| | - T Miao
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - F Miconi
- IPHC, Université de Strasbourg, CNRS/IN2P3, F-67037 Strasbourg, France
| | - D Mietlicki
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - A Mitra
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - H Miyake
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - S Moed
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - N Moggi
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - N K Mondal
- Tata Institute of Fundamental Research, Mumbai-400 005, India
| | - C S Moon
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Moore
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M J Morello
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- Scuola Normale Superiore, I-56127 Pisa, Italy
| | - A Mukherjee
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Mulhearn
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - Th Muller
- Institut für Experimentelle Kernphysik, Karlsruhe Institute of Technology, D-76131 Karlsruhe, Germany
| | - P Murat
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Mussini
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
- University of Bologna, I-40127 Bologna, Italy
| | - J Nachtman
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Y Nagai
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | | | - E Nagy
- CPPM, Aix-Marseille Université, CNRS/IN2P3, F-13288 Marseille Cedex 09, France
| | - I Nakano
- Okayama University, Okayama 700-8530, Japan
| | - A Napier
- Tufts University, Medford, Massachusetts 02155, USA
| | - M Narain
- Brown University, Providence, Rhode Island 02912, USA
| | - R Nayyar
- University of Arizona, Tucson, Arizona 85721, USA
| | - H A Neal
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - J P Negret
- Universidad de los Andes, Bogotá 111711, Colombia
| | - J Nett
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - P Neustroev
- Petersburg Nuclear Physics Institute, St. Petersburg 188300, Russia
| | - H T Nguyen
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - T Nigmanov
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - L Nodulman
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - S Y Noh
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - O Norniella
- University of Illinois, Urbana, Illinois 61801, USA
| | - T Nunnemann
- Ludwig-Maximilians-Universität München, 80539 München, Germany
| | - L Oakes
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - S H Oh
- Duke University, Durham, North Carolina 27708, USA
| | - Y D Oh
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - T Okusawa
- Osaka City University, Osaka 558-8585, Japan
| | - R Orava
- Division of High Energy Physics, Department of Physics, University of Helsinki, FIN-00014, Helsinki, Finland; Helsinki Institute of Physics, FIN-00014 Helsinki, Finland
| | - J Orduna
- Brown University, Providence, Rhode Island 02912, USA
| | - L Ortolan
- Institut de Fisica d'Altes Energies, ICREA, Universitat Autonoma de Barcelona, E-08193, Bellaterra (Barcelona), Spain
| | - N Osman
- CPPM, Aix-Marseille Université, CNRS/IN2P3, F-13288 Marseille Cedex 09, France
| | - C Pagliarone
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
| | - A Pal
- University of Texas, Arlington, Texas 76019, USA
| | - E Palencia
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - P Palni
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - V Papadimitriou
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - N Parashar
- Purdue University Calumet, Hammond, Indiana 46323, USA
| | - V Parihar
- Brown University, Providence, Rhode Island 02912, USA
| | - S K Park
- Korea Detector Laboratory, Korea University, Seoul 02841, Korea
| | - W Parker
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - R Partridge
- Brown University, Providence, Rhode Island 02912, USA
| | - N Parua
- Indiana University, Bloomington, Indiana 47405, USA
| | - A Patwa
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - G Pauletta
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- Gruppo Collegato di Udine, I-33100 Udine, Italy
- University of Udine, I-33100 Udine, Italy
| | - M Paulini
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - C Paus
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - B Penning
- Imperial College London, London SW7 2AZ, United Kingdom
| | - M Perfilov
- Moscow State University, Moscow 119991, Russia
| | - Y Peters
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - K Petridis
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - G Petrillo
- University of Rochester, Rochester, New York 14627, USA
| | - P Pétroff
- LAL, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91898 Orsay Cedex, France
| | - T J Phillips
- Duke University, Durham, North Carolina 27708, USA
| | - G Piacentino
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - E Pianori
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - J Pilot
- University of California, Davis, Davis, California 95616, USA
| | - K Pitts
- University of Illinois, Urbana, Illinois 61801, USA
| | - C Plager
- University of California, Los Angeles, Los Angeles, California 90024, USA
| | - M-A Pleier
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - V M Podstavkov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - L Pondrom
- University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - A V Popov
- Institute for High Energy Physics, Protvino, Moscow region 142281, Russia
| | - S Poprocki
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Potamianos
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - A Pranko
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - M Prewitt
- Rice University, Houston, Texas 77005, USA
| | - D Price
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - N Prokopenko
- Institute for High Energy Physics, Protvino, Moscow region 142281, Russia
| | - F Prokoshin
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - F Ptohos
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - G Punzi
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - J Qian
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - A Quadt
- II. Physikalisches Institut, Georg-August-Universität Göttingen, 37073 Göttingen, Germany
| | - B Quinn
- University of Mississippi, University, Mississippi 38677, USA
| | - P N Ratoff
- Lancaster University, Lancaster LA1 4YB, United Kingdom
| | - I Razumov
- Institute for High Energy Physics, Protvino, Moscow region 142281, Russia
| | - I Redondo Fernández
- Centro de Investigaciones Energeticas Medioambientales y Tecnologicas, E-28040 Madrid, Spain
| | - P Renton
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - M Rescigno
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma 1, I-00185 Roma, Italy
| | - F Rimondi
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
| | - I Ripp-Baudot
- IPHC, Université de Strasbourg, CNRS/IN2P3, F-67037 Strasbourg, France
| | - L Ristori
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - F Rizatdinova
- Oklahoma State University, Stillwater, Oklahoma 74078, USA
| | - A Robson
- Glasgow University, Glasgow G12 8QQ, United Kingdom
| | - T Rodriguez
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - S Rolli
- Tufts University, Medford, Massachusetts 02155, USA
| | - M Rominsky
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Ronzani
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - R Roser
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J L Rosner
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - A Ross
- Lancaster University, Lancaster LA1 4YB, United Kingdom
| | - C Royon
- Institute of Physics, Academy of Sciences of the Czech Republic, 182 21 Prague, Czech Republic
| | - P Rubinov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Ruchti
- University of Notre Dame, Notre Dame, Indiana 46556, USA
| | - F Ruffini
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Siena, I-56127 Pisa, Italy
| | - A Ruiz
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - J Russ
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - V Rusu
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Sajot
- LPSC, Université Joseph Fourier Grenoble 1, CNRS/IN2P3, Institut National Polytechnique de Grenoble, F-38026 Grenoble Cedex, France
| | - W K Sakumoto
- University of Rochester, Rochester, New York 14627, USA
| | | | | | - M P Sanders
- Ludwig-Maximilians-Universität München, 80539 München, Germany
| | - L Santi
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
- Gruppo Collegato di Udine, I-33100 Udine, Italy
- University of Udine, I-33100 Udine, Italy
| | - A S Santos
- LAFEX, Centro Brasileiro de Pesquisas Físicas, Rio de Janeiro, RJ 22290, Brazil
| | - K Sato
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - G Savage
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - V Saveliev
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Savitskyi
- Taras Shevchenko National University of Kyiv, Kiev 01601, Ukraine
| | - A Savoy-Navarro
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - L Sawyer
- Louisiana Tech University, Ruston, Louisiana 71272, USA
| | - T Scanlon
- Imperial College London, London SW7 2AZ, United Kingdom
| | - R D Schamberger
- State University of New York, Stony Brook, New York 11794, USA
| | - Y Scheglov
- Petersburg Nuclear Physics Institute, St. Petersburg 188300, Russia
| | - H Schellman
- Northwestern University, Evanston, Illinois 60208, USA
- Oregon State University, Corvallis, Oregon 97331, USA
| | - P Schlabach
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - E E Schmidt
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Schott
- Institut für Physik, Universität Mainz, 55099 Mainz, Germany
| | - C Schwanenberger
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - T Schwarz
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - R Schwienhorst
- Michigan State University, East Lansing, Michigan 48824, USA
| | - L Scodellaro
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - F Scuri
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
| | - S Seidel
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - Y Seiya
- Osaka City University, Osaka 558-8585, Japan
| | - J Sekaric
- University of Kansas, Lawrence, Kansas 66045, USA
| | - A Semenov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - H Severini
- University of Oklahoma, Norman, Oklahoma 73019, USA
| | - F Sforza
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- University of Pisa, I-56127 Pisa, Italy
| | - E Shabalina
- II. Physikalisches Institut, Georg-August-Universität Göttingen, 37073 Göttingen, Germany
| | - S Z Shalhout
- University of California, Davis, Davis, California 95616, USA
| | - V Shary
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - S Shaw
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - A A Shchukin
- Institute for High Energy Physics, Protvino, Moscow region 142281, Russia
| | - T Shears
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - P F Shepard
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - M Shimojima
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - O Shkola
- Taras Shevchenko National University of Kyiv, Kiev 01601, Ukraine
| | - M Shochet
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - I Shreyber-Tecker
- Institute for Theoretical and Experimental Physics, ITEP, Moscow 117259, Russia
| | - V Simak
- Czech Technical University in Prague, 116 36 Prague 6, Czech Republic
| | - A Simonenko
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - P Skubic
- University of Oklahoma, Norman, Oklahoma 73019, USA
| | - P Slattery
- University of Rochester, Rochester, New York 14627, USA
| | - K Sliwa
- Tufts University, Medford, Massachusetts 02155, USA
| | - J R Smith
- University of California, Davis, Davis, California 95616, USA
| | - F D Snider
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G R Snow
- University of Nebraska, Lincoln, Nebraska 68588, USA
| | - J Snow
- Langston University, Langston, Oklahoma 73050, USA
| | - S Snyder
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | | | - H Song
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - L Sonnenschein
- III. Physikalisches Institut A, RWTH Aachen University, 52056 Aachen, Germany
| | - V Sorin
- Institut de Fisica d'Altes Energies, ICREA, Universitat Autonoma de Barcelona, E-08193, Bellaterra (Barcelona), Spain
| | - K Soustruznik
- Faculty of Mathematics and Physics, Center for Particle Physics, Charles University, 116 36 Prague 1, Czech Republic
| | - R St Denis
- Glasgow University, Glasgow G12 8QQ, United Kingdom
| | - M Stancari
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Stark
- LPSC, Université Joseph Fourier Grenoble 1, CNRS/IN2P3, Institut National Polytechnique de Grenoble, F-38026 Grenoble Cedex, France
| | - N Stefaniuk
- Taras Shevchenko National University of Kyiv, Kiev 01601, Ukraine
| | - D Stentz
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D A Stoyanova
- Institute for High Energy Physics, Protvino, Moscow region 142281, Russia
| | - M Strauss
- University of Oklahoma, Norman, Oklahoma 73019, USA
| | - J Strologas
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - Y Sudo
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - A Sukhanov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - I Suslov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - L Suter
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - P Svoisky
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - K Takemasa
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - Y Takeuchi
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - J Tang
- Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - M Tecchio
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - P K Teng
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - J Thom
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - E Thomson
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - V Thukral
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - M Titov
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - D Toback
- Mitchell Institute for Fundamental Physics and Astronomy, Texas A&M University, College Station, Texas 77843, USA
| | - S Tokar
- Comenius University, 842 48 Bratislava, Slovakia; Institute of Experimental Physics, 040 01 Kosice, Slovakia
| | - V V Tokmenin
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - K Tollefson
- Michigan State University, East Lansing, Michigan 48824, USA
| | - T Tomura
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - D Tonelli
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Torre
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - D Torretta
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Totaro
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
| | - M Trovato
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- Scuola Normale Superiore, I-56127 Pisa, Italy
| | - Y-T Tsai
- University of Rochester, Rochester, New York 14627, USA
| | - D Tsybychev
- State University of New York, Stony Brook, New York 11794, USA
| | - B Tuchming
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - C Tully
- Princeton University, Princeton, New Jersey 08544, USA
| | - F Ukegawa
- University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - S Uozumi
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - L Uvarov
- Petersburg Nuclear Physics Institute, St. Petersburg 188300, Russia
| | - S Uvarov
- Petersburg Nuclear Physics Institute, St. Petersburg 188300, Russia
| | - S Uzunyan
- Northern Illinois University, DeKalb, Illinois 60115, USA
| | - R Van Kooten
- Indiana University, Bloomington, Indiana 47405, USA
| | | | - N Varelas
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - E W Varnes
- University of Arizona, Tucson, Arizona 85721, USA
| | - I A Vasilyev
- Institute for High Energy Physics, Protvino, Moscow region 142281, Russia
| | - F Vázquez
- University of Florida, Gainesville, Florida 32611, USA
| | - G Velev
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - C Vellidis
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Y Verkheev
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - C Vernieri
- Istituto Nazionale di Fisica Nucleare Pisa, I-56127 Pisa, Italy
- Scuola Normale Superiore, I-56127 Pisa, Italy
| | - L S Vertogradov
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - M Verzocchi
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Vesterinen
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - M Vidal
- Purdue University, West Lafayette, Indiana 47907, USA
| | - D Vilanova
- CEA Saclay, Irfu, SPP, F-91191 Gif-Sur-Yvette Cedex, France
| | - R Vilar
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - J Vizán
- Instituto de Fisica de Cantabria, CSIC-University of Cantabria, 39005 Santander, Spain
| | - M Vogel
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - P Vokac
- Czech Technical University in Prague, 116 36 Prague 6, Czech Republic
| | - G Volpi
- Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, I-00044 Frascati, Italy
| | - P Wagner
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - H D Wahl
- Florida State University, Tallahassee, Florida 32306, USA
| | - R Wallny
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M H L S Wang
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S M Wang
- Institute of Physics, Academia Sinica, Taipei, Taiwan 11529, Republic of China
| | - J Warchol
- University of Notre Dame, Notre Dame, Indiana 46556, USA
| | - D Waters
- University College London, London WC1E 6BT, United Kingdom
| | - G Watts
- University of Washington, Seattle, Washington 98195, USA
| | - M Wayne
- University of Notre Dame, Notre Dame, Indiana 46556, USA
| | - J Weichert
- Institut für Physik, Universität Mainz, 55099 Mainz, Germany
| | | | - W C Wester
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Whiteson
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - A B Wicklund
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - S Wilbur
- University of California, Davis, Davis, California 95616, USA
| | - H H Williams
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | | | - G W Wilson
- University of Kansas, Lawrence, Kansas 66045, USA
| | - J S Wilson
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - P Wilson
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - B L Winer
- The Ohio State University, Columbus, Ohio 43210, USA
| | - P Wittich
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Wobisch
- Louisiana Tech University, Ruston, Louisiana 71272, USA
| | - S Wolbers
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - H Wolfmeister
- The Ohio State University, Columbus, Ohio 43210, USA
| | - D R Wood
- Northeastern University, Boston, Massachusetts 02115, USA
| | - T Wright
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - X Wu
- University of Geneva, CH-1211 Geneva 4, Switzerland
| | - Z Wu
- Baylor University, Waco, Texas 76798, USA
| | - T R Wyatt
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - Y Xie
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Yamada
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Yamamoto
- Osaka City University, Osaka 558-8585, Japan
| | - D Yamato
- Osaka City University, Osaka 558-8585, Japan
| | - S Yang
- University of Science and Technology of China, Hefei 230026, People's Republic of China
| | - T Yang
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - U K Yang
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - Y C Yang
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - W-M Yao
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - T Yasuda
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Y A Yatsunenko
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russia
| | - W Ye
- State University of New York, Stony Brook, New York 11794, USA
| | - Z Ye
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G P Yeh
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Yi
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - H Yin
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Yip
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - J Yoh
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Yorita
- Waseda University, Tokyo 169, Japan
| | - T Yoshida
- Osaka City University, Osaka 558-8585, Japan
| | - S W Youn
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G B Yu
- Duke University, Durham, North Carolina 27708, USA
| | - I Yu
- Center for High Energy Physics: Kyungpook National University, Daegu 702-701, Korea; Seoul National University, Seoul 151-742, Korea; Sungkyunkwan University, Suwon 440-746, Korea; Korea Institute of Science and Technology Information, Daejeon 305-806, Korea; Chonnam National University, Gwangju 500-757, Korea; Chonbuk National University, Jeonju 561-756, Korea; Ewha Womans University, Seoul 120-750, Korea
| | - J M Yu
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - A M Zanetti
- Istituto Nazionale di Fisica Nucleare Trieste, I-33100 Udine, Italy
| | - Y Zeng
- Duke University, Durham, North Carolina 27708, USA
| | - J Zennamo
- State University of New York, Buffalo, New York 14260, USA
| | - T G Zhao
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - B Zhou
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - C Zhou
- Duke University, Durham, North Carolina 27708, USA
| | - J Zhu
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - M Zielinski
- University of Rochester, Rochester, New York 14627, USA
| | - D Zieminska
- Indiana University, Bloomington, Indiana 47405, USA
| | - L Zivkovic
- LPNHE, Universités Paris VI and VII, CNRS/IN2P3, F-75005 Paris, France
| | - S Zucchelli
- Istituto Nazionale di Fisica Nucleare Bologna, I-40127 Bologna, Italy
- University of Bologna, I-40127 Bologna, Italy
| |
Collapse
|
69
|
Lee JS, Han P, Song E, Kim D, Lee H, Labowsky M, Taavitsainen J, Ylä-Herttuala S, Hytönen J, Gülcher M, Perampaladas K, Sinusas AJ, Martin J, Mathur A, Fahmy TM. Magnetically Coated Bioabsorbable Stents for Renormalization of Arterial Vessel Walls after Stent Implantation. Nano Lett 2018; 18:272-281. [PMID: 29268605 DOI: 10.1021/acs.nanolett.7b04096] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
The insertion of a stent in diseased arteries is a common endovascular procedure that can be compromised by the development of short- and long-term inflammatory responses leading to restenosis and thrombosis, respectively. While treatment with drugs, either systemic or localized, has decreased the incidence of restenosis and thrombosis these complications persist and are associated with a high mortality in those that present with stent thrombosis. We reasoned that if stents could be made to undergo accelerated endothelialization in the deployed region, then such an approach would further decrease the occurrence of stent thrombosis and restenosis thereby improving clinical outcomes. Toward that objective, the first step necessitated efficient capture of progenitor stem cells, which eventually would become the new endothelium. To achieve this objective, we engineered intrinsic ferromagnetism within nonmagnetizable, biodegradable magnesium (Mg) bare metal stents. Mg stents were coated with biodegradable polylactide (PLA) polymer embedding magnetizable iron-platinum (FePt) alloy nanoparticles, nanomagnetic particles, nMags, which increased the surface area and hence magnetization of the stent. nMags uniformly distributed on stents enabled capture, under flow, up to 50 mL/min, of systemically injected iron-oxide-labeled (IO-labeled) progenitor stem cells. Critical parameters enhancing capture efficiency were optimized, and we demonstrated the generality of the approach by showing that nMag-coated stents can capture different cell types. Our work is a potential paradigm shift in engineering stents because implants are rendered as tissue in the body, and this "natural stealthiness" reduces or eliminates issues associated with pro-inflammatory immune responses postimplantation.
Collapse
Affiliation(s)
| | | | | | - D Kim
- Department of Pharmaceutical Sciences, Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center , College Station, Texas 77843, United States
| | | | - M Labowsky
- Ansama Research LLC , Wayne, New Jersey 07470, United States
| | - J Taavitsainen
- A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland , Kuopio 70210, Finland
| | - S Ylä-Herttuala
- A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland , Kuopio 70210, Finland
| | - J Hytönen
- A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland , Kuopio 70210, Finland
| | - M Gülcher
- QualiMed Innovative Medizinprodukte GmbH , Winsen 21423, Germany
| | - K Perampaladas
- Magnus Life Science, Bloomsbury , London WC1E 6JF, United Kingdom
| | | | | | - A Mathur
- Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London , London E1 4NS, United Kingdom
| | | |
Collapse
|
70
|
Lee J, Seo SW, Yang JJ, Jang YK, Lee JS, Kim YJ, Chin J, Lee JM, Kim ST, Lee KH, Lee JH, Kim JS, Kim S, Yoo H, Lee AY, Na DL, Kim HJ. Longitudinal cortical thinning and cognitive decline in patients with early- versus late-stage subcortical vascular mild cognitive impairment. Eur J Neurol 2017; 25:326-333. [PMID: 29082576 DOI: 10.1111/ene.13500] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2017] [Accepted: 10/20/2017] [Indexed: 11/30/2022]
Abstract
BACKGROUND AND PURPOSE Biomarker changes in cognitively impaired patients with small vessel disease are largely unknown. The rate of amyloid/lacune progression, cortical thinning and cognitive decline were evaluated in subcortical vascular mild cognitive impairment (svMCI) patients. METHODS Seventy-two svMCI patients were divided into early stage (ES-svMCI, n = 39) and late stage (LS-svMCI, n = 33) according to their Clinical Dementia Rating Sum of Boxes score. Patients were annually followed up with neuropsychological tests and brain magnetic resonance imaging for 3 years, and underwent a second [11 C] Pittsburgh compound B (PiB) positron emission tomography scan within a mean interval of 32.4 months. RESULTS There was no difference in the rate of increase in PiB uptake or lacune number between the ES-svMCI and LS-svMCI. However, LS-svMCI showed more rapid cortical thinning and cognitive decline than did the ES-svMCI. CONCLUSIONS We suggest that, whilst the rate of change in pathological burden did not differ between ES-svMCI and LS-svMCI, cortical thinning and cognitive decline progressed more rapidly in the LS-svMCI.
Collapse
Affiliation(s)
- J Lee
- Department of Neurology, Chungnam National University Hospital, Daejeon, Korea.,Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.,Neuroscience Center, Samsung Medical Center, Seoul, Korea
| | - S W Seo
- Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.,Neuroscience Center, Samsung Medical Center, Seoul, Korea.,Department of Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.,Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Korea
| | - J-J Yang
- Department of Biomedical Engineering, Hanyang University, Seoul, Korea
| | - Y K Jang
- Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.,Neuroscience Center, Samsung Medical Center, Seoul, Korea
| | - J S Lee
- Department of Medicine, Graduate School, Kyung Hee University, Seoul, Korea
| | - Y J Kim
- Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.,Neuroscience Center, Samsung Medical Center, Seoul, Korea.,Department of Neurology, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Gangwon-do, Korea
| | - J Chin
- Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.,Neuroscience Center, Samsung Medical Center, Seoul, Korea
| | - J M Lee
- Department of Biomedical Engineering, Hanyang University, Seoul, Korea
| | - S T Kim
- Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - K-H Lee
- Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - J H Lee
- Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - J S Kim
- Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - S Kim
- Biostatistics Team, Samsung Biomedical Research Institute, Seoul, Korea
| | - H Yoo
- Biostatistics Team, Samsung Biomedical Research Institute, Seoul, Korea
| | - A Y Lee
- Department of Neurology, Chungnam National University Hospital, Daejeon, Korea
| | - D L Na
- Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.,Neuroscience Center, Samsung Medical Center, Seoul, Korea.,Department of Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea
| | - H J Kim
- Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.,Neuroscience Center, Samsung Medical Center, Seoul, Korea
| |
Collapse
|
71
|
Paik JH, Jung HM, Yun SH, Lee JS, Han SB, Kim JS, Kim JH. Spontaneous Rupture of Abdominal Aorta after Seizure in a 23-Year-Old Woman: A Case Report. HONG KONG J EMERG ME 2017. [DOI: 10.1177/102490791402100201] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Spontaneous non-aneurysmal aortic rupture is a rare and life threatening clinical entity. A 23-year-old female patient who visited a nearby hospital due to intractable seizure was transferred to our hospital with the impression of hypotension and decreased level of haemoglobin. She had a history of seizure attacks once a month. However, in the 2 weeks before presentation, the frequency of seizure attacks had increased to 2 to 3 times a day. An abdominal-pelvic computed tomogram scan showed extravasation of contrast from the abdominal aorta at L3 level. An emergency laparotomy revealed a 0.3 cm diameter tear in the posterior wall of the aorta, superior to the iliac bifurcation. We discuss the mechanism of spontaneous aortic rupture and the possibility of aortic rupture related to seizure attacks. (Hong Kong j.emerg.med. 2014;21:103-106)
Collapse
|
72
|
Seok J, Lee JS, Jeong KY, Lee CM. Association between Systolic Blood Pressure after Thrombolysis and Early Neurological Improvement in Ischaemic Stroke Patients. HONG KONG J EMERG ME 2017. [DOI: 10.1177/102490791702400304] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Introduction This study aimed to evaluate the relationship between systolic blood pressures (SBPs) within 12 hours after intravenous recombinant tissue plasminogen activator (rtPA) treatment and early neurological outcomes. Methods This was a retrospective observational study of acute ischaemic stroke (AIS) patients who received intravenous rtPA administration. SBPs at the time of rtPA bolus and thereafter every hour were collected. The mean, standard deviation, and coefficient of variation values of SBP during the periods of 0-2 h, 2-6 h, and 6-12 h were calculated. The primary outcome was major neurologic improvement (MNI) at 24 hours after thrombolysis. Results Serial measures of SBPs revealed different 12-hour courses between the patients with and without MNI. The difference of SBP tendency was statistically significant (p=0.013). In univariate analysis, patients with MNI showed lower levels of mean SBPs during the periods of 2-6 h and 6-12 h (p=0.030 and p=0.005, respectively), and higher frequency of very early neurologic improvement (VENI) at the end of rtPA infusion (p<0.001). In logistic regression analysis, VENI at 1 h, mean SBP value during 6-12 h, and atrial fibrillation were independently related to MNI at 24 h. Conclusions SBP level during the first 12 hours after intravenous rtPA treatment may be an important clinical factor that is associated with early neurological improvement of AIS patients.
Collapse
Affiliation(s)
- J Seok
- Kyung Hee University Medical Center, Department of Emergency Medicine, Seoul, Korea
| | - JS Lee
- Kyung Hee University Medical Center, Department of Emergency Medicine, Seoul, Korea
| | - KY Jeong
- Kyung Hee University Medical Center, Department of Emergency Medicine, Seoul, Korea
| | - CM Lee
- Kyung Hee University, Department of Medicine, Graduate School, Seoul, Korea
| |
Collapse
|
73
|
Ye RR, Peterson DR, Seemann F, Kitamura SI, Lee JS, Lau TCK, Tsui SKW, Au DWT. Immune competence assessment in marine medaka (Orzyias melastigma)-a holistic approach for immunotoxicology. Environ Sci Pollut Res Int 2017; 24:27687-27701. [PMID: 27473621 DOI: 10.1007/s11356-016-7208-x] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/15/2016] [Accepted: 07/08/2016] [Indexed: 06/06/2023]
Abstract
Many anthropogenic pollutants in coastal marine environments can induce immune impairments in wild fish and reduce their survival fitness. There is a pressing need to establish sensitive and high throughput in vivo tools to systematically evaluate the immunosuppressive effects of contaminants in marine teleosts. This study reviewed a battery of in vivo immune function detection technologies established for different biological hierarchies at molecular (immune function pathways and genes by next generation sequencing (NGS)), cellular (leukocytes profiles by flow cytometry), tissues/organ system (whole adult histo-array), and organism (host resistance assays (HRAs)) levels, to assess the immune competence of marine medaka Oryzias melastigma. This approach enables a holistic assessment of fish immune competence under different chemical exposure or environmental scenarios. The data obtained will also be useful to unravel the underlying immunotoxic mechanisms. Intriguingly, NGS analysis of hepatic immune gene expression profiles (male > female) are in support of the bacterial HRA findings, in which infection-induced mortality was consistently higher in females than in males. As such, reproductive stages and gender-specific responses must be taken into consideration when assessing the risk of immunotoxicants in the aquatic environment. The distinct phenotypic sexual dimorphism and short generation time (3 months) of marine medaka offer additional advantages for sex-related immunotoxicological investigation.
Collapse
Affiliation(s)
- Roy R Ye
- State Key Laboratory in Marine Pollution, Department of Biology and Chemistry, City University of Hong Kong, Kowloon Tong, Hong Kong
| | - Drew R Peterson
- State Key Laboratory in Marine Pollution, Department of Biology and Chemistry, City University of Hong Kong, Kowloon Tong, Hong Kong
| | - Frauke Seemann
- State Key Laboratory in Marine Pollution, Department of Biology and Chemistry, City University of Hong Kong, Kowloon Tong, Hong Kong
| | - Shin-Ichi Kitamura
- Centre for Marine Environmental Studies, Ehime University, Matsuyama, 790-8577, Japan
| | - J S Lee
- Department of Biological Science, College of Science, Sungkyunkwan University, Suwon, 440-746, South Korea
| | - Terrance C K Lau
- Department of Biomedical Sciences, City University of Hong Kong, Kowloon Tong, Hong Kong
| | - Stephen K W Tsui
- School of Biomedical Sciences, The Chinese University of Hong Kong, New Territories, Hong Kong
| | - Doris W T Au
- State Key Laboratory in Marine Pollution, Department of Biology and Chemistry, City University of Hong Kong, Kowloon Tong, Hong Kong.
- Shenzhen Key Laboratory for the Sustainable Use of Marine Biodiversity, Research Centre for the Oceans and Human Health, Shenzhen Research Institute, City University of Hong Kong, Shenzhen, 518057, China.
| |
Collapse
|
74
|
Park MY, Lee JS, Jin HJ, You HS, Kim GW, Ko HC, Kim BS, Kim MB, Kim HS. Localized argyria: troublesome side-effect of acupuncture. J Eur Acad Dermatol Venereol 2017; 32:e62-e65. [PMID: 28833654 DOI: 10.1111/jdv.14526] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- M Y Park
- Department of Dermatology, School of Medicine, Pusan National University, Busan, Korea
| | - J S Lee
- Department of Mechanical Engineering, Pohang University of Science and Technology (POSTECH), Gyeongbuk, Korea
| | - H J Jin
- Department of Dermatology, School of Medicine, Pusan National University, Busan, Korea
| | - H S You
- Department of Dermatology, School of Medicine, Pusan National University, Busan, Korea
| | - G W Kim
- Department of Dermatology, School of Medicine, Pusan National University, Busan, Korea
| | - H C Ko
- Department of Dermatology, School of Medicine, Pusan National University, Busan, Korea
| | - B S Kim
- Department of Dermatology, School of Medicine, Pusan National University, Busan, Korea.,Biomedical Research Institute, Pusan National University Hospital, Busan, Korea
| | - M B Kim
- Department of Dermatology, School of Medicine, Pusan National University, Busan, Korea.,Biomedical Research Institute, Pusan National University Hospital, Busan, Korea
| | - H S Kim
- Department of Dermatology, School of Medicine, Pusan National University, Busan, Korea.,Biomedical Research Institute, Pusan National University Hospital, Busan, Korea
| |
Collapse
|
75
|
Park YS, Lee SH, Lim CK, Choi HW, An JH, Park CW, Lee HS, Lee JS, Seo JT. Paternal age as an independent factor does not affect embryo quality and pregnancy outcomes of testicular sperm extraction-intracytoplasmic sperm injection in azoospermia. Andrologia 2017; 50. [PMID: 28703337 DOI: 10.1111/and.12864] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/27/2017] [Indexed: 12/25/2022] Open
Abstract
This study was performed to evaluate the independent influence of paternal age affecting embryo development and pregnancy using testicular sperm extraction (TESE)-intracytoplasmic sperm injection (ICSI) in obstructive azoospermia (OA) and nonobstructive azoospermia (NOA). Paternal patients were divided into the following groups: ≤30 years, 31-35 years, 36-40 years, 41-45 years and ≥46 years. There were no differences in the rates of fertilisation or embryo quality according to paternal and maternal age. However, clinical pregnancy and implantation rates were significantly lower between those ≥46 years of paternal age compared with other age groups. Fertilisation rate was higher in the OA than the NOA, while embryo quality, pregnancy and delivery results were similar. Clinical pregnancy and implantation rates were significantly lower for patients ≥46 years of paternal age compared with younger age groups. In conclusion, fertilisation using TESE in azoospermia was not affected by the independent influence of paternal age; however, as maternal age increased concomitantly with paternal age, rates of pregnancy and delivery differed between those with paternal age <41 years and ≥46 years. Therefore, paternal age ≥46 years old should be considered when applying TESE-ICSI in cases of azoospermia, and patients should be advised of the associated low pregnancy rates.
Collapse
Affiliation(s)
- Y S Park
- Laboratory of Reproductive Medicine, Cheil General Hospital & Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea
| | - S H Lee
- Laboratory of Reproductive Medicine, Cheil General Hospital & Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea.,Division of Developmental Biology and Physiology, School of Biosciences and Chemistry, Sungshin Women's University, Seoul, Korea
| | - C K Lim
- Laboratory of Reproductive Medicine, Cheil General Hospital & Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea
| | - H W Choi
- Laboratory of Reproductive Medicine, Cheil General Hospital & Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea
| | - J H An
- Laboratory of Reproductive Medicine, Cheil General Hospital & Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea
| | - C W Park
- Department of Obstetrics and Gynecology, Cheil General Hospital & Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea
| | - H S Lee
- Department of Urology, Cheil General Hospital & Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea
| | - J S Lee
- Department of Urology, Cheil General Hospital & Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea
| | - J T Seo
- Department of Urology, Cheil General Hospital & Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea
| |
Collapse
|
76
|
Lee JS, Kim JM, Seok J, Kim BJ. Correlation between socio-economic status and atopic dermatitis in Korean adults: the Korea national health and nutrition examination survey (2007-2014). J Eur Acad Dermatol Venereol 2017; 31:1509-1515. [PMID: 28516452 DOI: 10.1111/jdv.14343] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2016] [Accepted: 04/19/2017] [Indexed: 11/30/2022]
Abstract
INTRODUCTION Atopic dermatitis (AD) is one of the most common allergic diseases. Its prevalence has been increasing in recent decades. Socio-economic status is well-known risk factor of allergic diseases. OBJECTIVE This study was performed to investigate the relationship between socio-economic status and AD in Korean adults. METHODS Data were acquired from 47 351 men and women, ≥19 years of age who participated in the Korea National Health and Nutrition Examination Surveys (KNHANES) conducted from 2007 to 2014. The presence of AD was based on self-reported physician diagnosis of AD in the Health Interview Surveys. RESULTS The prevalence of AD was 3.1%, which decreased with increasing age. In univariate analysis, adults with AD were prone to be female, younger, never-married, well educated, lower household members, and urban dwelling (all P < 0.01). Monthly family income and smoking status were not associated with the presence of AD. The prevalence of hypertension, diabetes mellitus and asthma was higher in AD subjects (all P < 0.01), while obesity was not associated with adult AD. After adjusting for confounders, logistic regression analysis showed female sex (adjusted odds ratio [aOR]: 1.483, 95% CI: 1.268-1.734), age (P < 0.01), marital status (Single: aOR: 1.307, 95% CI: 1.012-1.690; Never-married: aOR: 1.938, 95% CI: 1.513-2.482), urban residence (aOR: 1.281, 95% CI: 1.045-1.569) and asthma (aOR: 1.788, 95% CI: 1.416-2.258) were associated with higher prevalence of AD (all P < 0.01). CONCLUSION Female sex, age, marital status, urban residence, and the presence of asthma are important risk factors of the prevalence of AD in Korean adults.
Collapse
Affiliation(s)
- J S Lee
- Department of Pediatrics, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea
| | - J M Kim
- Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea
| | - J Seok
- Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea
| | - B J Kim
- Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea
| |
Collapse
|
77
|
Park MJ, Kim JP, Lee HI, Lim TK, Jung HS, Lee JS. Is a short arm cast appropriate for stable distal radius fractures in patients older than 55 years? A randomized prospective multicentre study. J Hand Surg Eur Vol 2017; 42:487-492. [PMID: 28490225 DOI: 10.1177/1753193417690464] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
UNLABELLED We conducted a prospective randomized, multicentre study to compare short arm and long arm plaster casts for the treatment of stable distal radius fracture in patients older than 55 years. We randomly assigned patients over the age of 55 years who had stable distal radius fracture to either a short arm or long arm plaster cast at the first review 1 week after their injury. Radiographic and clinical follow-up was conducted at 1, 3, 5, 12 and 24 weeks following their injury. Also, degree of disability caused by each cast immobilization was evaluated at the patient's visit to remove the cast. There were no significant differences in radiological parameters between the groups except for volar tilt. Despite these differences in volar tilt, neither functional status as measured by the Disabilities of the Arm, Shoulder and Hand, nor visual analogue scale was significantly different between the groups. However, the mean score of disability caused by plaster cast immobilization and the incidence rate of shoulder pain were significantly higher in patients who had a long plaster cast. Our findings suggest that a short arm cast is as effective as a long arm cast for stable distal radius fractures in the elderly. Furthermore, it is more comfortable and introduces less restriction on daily activities. LEVEL OF EVIDENCE II.
Collapse
Affiliation(s)
- M J Park
- 1 Department of Orthopedic Surgery, SungKyunKwan University School of Medicine, Seoul, Korea
| | - J P Kim
- 2 Department of Orthopaedic Surgery, Dankook University, Cheonan, Korea
| | - H I Lee
- 3 Department of Orthopaedic Surgery, University of Ulsan College of Medicine, Gangneung, Korea
| | - T K Lim
- 4 Department of Orthopaedic Surgery, Eulji University School of Medicine, Seoul, Korea
| | - H S Jung
- 5 Department of Orthopedic Surgery, Medical Center of Chung-Ang University School of Medicine, Seoul, Korea
| | - J S Lee
- 5 Department of Orthopedic Surgery, Medical Center of Chung-Ang University School of Medicine, Seoul, Korea
| |
Collapse
|
78
|
Kang S, Lee JS, Park J, Park SS. Staged lengthening and reconstruction for children with a leg-length discrepancy after excision of an osteosarcoma around the knee. Bone Joint J 2017; 99-B:401-408. [PMID: 28249982 DOI: 10.1302/0301-620x.99b3.38018] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/07/2016] [Accepted: 11/25/2016] [Indexed: 11/05/2022]
Abstract
AIMS Children treated for osteosarcoma around the knee often have a substantial leg-length discrepancy at skeletal maturity. The aim of this study was to investigate the results of staged skeletal reconstruction after a leg lengthening procedure using an external fixator in these patients. PATIENTS AND METHODS We reviewed 11 patients who underwent staged reconstruction with either an arthroplasty (n = 6) or an arthrodesis (n = 5). A control group of 11 patients who had undergone wide excision and concurrent reconstruction with an arthroplasty were matched for gender, location, and size of tumour. We investigated the change in leg-length discrepancy, function as assessed by the Musculoskeletal Tumor Society Scale (MSTS) score and complications. RESULTS A mean 5.2 cm (1.7 to 8.9) of lengthening was achieved. The mean MSTS scores significantly improved after staged reconstruction (p = 0.003) but were still worse than those of the control group (p = 0.049). However, the MSTS scores of the arthroplasty subgroup were comparable with those of the controls, although the extensor lag was greater and the range of movement was less. The patient group experienced more complications, but all of these resolved. CONCLUSION Approximately 5 cm of lengthening and significant functional improvement can be achieved by staged reconstruction and lengthening, without major complications. Although it has limitations, this method of treatment seems to be a satisfactory surgical option for growing children with a significant leg-length discrepancy after excision of an osteosarcoma around the knee. Cite this article: Bone Joint J 2017;99-B:401-8.
Collapse
Affiliation(s)
- S Kang
- University of Ulsan College of Medicine, 88, Olympic-ro, 43-gil, Songpa-gu, Seoul 05505, South, Korea
| | - J S Lee
- University of Ulsan College of Medicine, 88, Olympic-ro, 43-gil, Songpa-gu, Seoul 05505, South, Korea
| | - J Park
- University of Ulsan College of Medicine, 88, Olympic-ro, 43-gil, Songpa-gu, Seoul 05505, South, Korea
| | - S-S Park
- University of Ulsan College of Medicine, 88, Olympic-ro, 43-gil, Songpa-gu, Seoul 05505, South, Korea
| |
Collapse
|
79
|
Kim W, Kim BG, Lee JS, Lee CK, Yeon JE, Chang MS, Kim JH, Kim H, Yi S, Lee J, Cho JY, Kim SG, Lee JH, Kim YJ. Randomised clinical trial: the efficacy and safety of oltipraz, a liver X receptor alpha-inhibitory dithiolethione in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2017; 45:1073-1083. [PMID: 28225186 DOI: 10.1111/apt.13981] [Citation(s) in RCA: 52] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/19/2016] [Revised: 05/31/2016] [Accepted: 01/22/2017] [Indexed: 12/11/2022]
Abstract
BACKGROUND Oltipraz is a synthetic dithiolethione with an antisteatotic effect by inhibiting the activity of liver X receptor alpha (LXR-α). Recent studies demonstrated the disruptive role of oltipraz on LXR-α-dependent lipogenesis in hepatocytes and a high-fat diet mouse model. AIM To evaluate the efficacy and safety of oltipraz for reducing liver fat in subjects with non-alcoholic fatty liver disease (NAFLD). METHODS We performed a multicentre, double-blind, placebo-controlled, phase II study. Subjects with a liver fat >20% and hypertransaminasemia were randomised to the three groups: placebo (n = 22), 30 mg of oltipraz (n = 22) or 60 mg of oltipraz (n = 24) twice daily for 24 weeks. Changes in the liver fat from baseline to 24 weeks quantified using magnetic resonance spectroscopy were the primary outcome. RESULTS Compared with the placebo group (-3.2 ± 11.1%), absolute changes in the liver fat content increased in a dose-dependent manner: -7.7 ± 7.0% and -13.9 ± 10.7% for the low-dose and high-dose groups (P = 0.13 and P < 0.01). Per cent reduction in the liver fat content was also significantly greater in the high-dose group than in the placebo group (-34.6 ± 29.4% vs. -0.6 ± 62.9%, P = 0.046). Body mass indices (-1.0 ± 0.9% vs. -0.5 ± 1.4%, P = 0.04) significantly decreased in the high-dose group compared to the placebo group. However, absolute changes in insulin resistance, liver enzymes, lipids and cytokines were not significantly different among groups. The incidence of adverse events was comparable among groups. CONCLUSIONS Twenty-four-week oltipraz treatment significantly reduced the liver fat content in patients with NAFLD. Clinicaltrials.gov (NCT01373554).
Collapse
|
80
|
Baek JK, Lee JS, Kim TH, Kim YH, Han DJ, Hong SK. Four-Year Experience With Extracorporeal Membrane Oxygenation for Kidney Transplant Patients With Severe Refractory Cardiopulmonary Insufficiency. Transplant Proc 2017; 48:2080-3. [PMID: 27569948 DOI: 10.1016/j.transproceed.2016.04.022] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2015] [Revised: 04/03/2016] [Accepted: 04/25/2016] [Indexed: 11/30/2022]
Abstract
BACKGROUND Kidney transplant (KT) recipients are vulnerable to infections because of their immunosuppressive treatments, and they occasionally exhibit serious acute cardiopulmonary dysfunction. The purpose of this study was to report the clinical outcomes of using extracorporeal membrane oxygenation (ECMO) in KT recipients and to identify risk factors for ECMO weaning failure. METHODS We retrospectively reviewed the electronic medical records of KT patients who experienced severe cardiopulmonary dysfunction refractory to conventional therapy and received ECMO at the Asan Medical Center Surgical Intensive Care Unit between December 2010 and December 2014. RESULTS During the 4-year study period, 12 KT patients required ECMO management. Six of these patients were successfully weaned from ECMO; the mean duration of ECMO support was 9.1 days (range, 3.5-15.1 days). Indications for ECMO included pneumonia (8 cases required venovenous ECMO and 1 case required venoarterial [VA] ECMO), stress-induced cardiomyopathy due to fungemia (1 case required VA ECMO), and septic shock due to either urinary tract infection or unknown origin (2 cases required VA ECMO). In assessing risk factors leading to a failure of ECMO weaning, the pH on arterial blood gas analysis performed just before the beginning of this intervention was significantly lower in the nonsurvivors than in the survivors (P = .046). CONCLUSIONS ECMO can be a beneficial rescue therapy in immunosuppressed patients with cardiopulmonary dysfunction refractory to treatment. Severe acidosis before the administration of EMCO is a major determinant of ECMO weaning failure.
Collapse
Affiliation(s)
- J-K Baek
- Division of Trauma and Surgical Critical Care, Department of Surgery, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Republic of Korea
| | - J S Lee
- Division of Trauma and Surgical Critical Care, Department of Surgery, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Republic of Korea
| | - T H Kim
- Division of Trauma and Surgical Critical Care, Department of Surgery, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Republic of Korea
| | - Y H Kim
- Division of Kidney and Pancreas Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Republic of Korea
| | - D J Han
- Division of Kidney and Pancreas Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Republic of Korea
| | - S K Hong
- Division of Trauma and Surgical Critical Care, Department of Surgery, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Republic of Korea.
| |
Collapse
|
81
|
Han JW, Kim MS, Song MS, Kang BY, Cho BK, Lee JS. Application of emitter-sample hybrid terahertz time-domain spectroscopy to investigate temperature-dependent optical constants of doped InAs. Appl Opt 2017; 56:2529-2534. [PMID: 28375363 DOI: 10.1364/ao.56.002529] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
We investigate temperature-dependent carrier dynamics of InAs crystal by using reflection-type terahertz time-domain spectroscopy, particularly with a recently developed emitter-sample hybrid structure. We successfully obtain the optical conductivity in a terahertz frequency of bulk InAs whose dc conductivity is in the range of 100-150 Ω-1 cm-1. We find that both real and imaginary parts of the optical conductivity can be fit well with the simple Drude model, and the free-carrier density and the scattering rate obtained from the fit are in good agreement with corresponding values obtained by using other techniques, such as the Hall measurement and the dc-resistivity measurement. These results clearly demonstrate that the proposed technique of adopting the emitter-sample hybrid structure can be exploited to determine temperature-dependent optical constants in a reflection geometry and hence to investigate electrodynamics of bulk metallic systems.
Collapse
|
82
|
Park DJ, Kang JH, Lee JW, Lee KE, Kim TJ, Park YW, Lee JS, Choi YD, Lee SS. Risk factors to predict the development of chronic kidney disease in patients with lupus nephritis. Lupus 2017; 26:1139-1148. [DOI: 10.1177/0961203317694257] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
Objectives We analyzed the clinical follow-up results of 88 lupus nephritis patients to find prognostic factors for the development of chronic kidney disease in ethnically homogeneous Korean patients with biopsy-proven lupus nephritis. Methods Sociodemographic, clinical, laboratory, and treatment-related data at the time of kidney biopsy and during follow-up were obtained. Renal biopsy specimens were reclassified according to the International Society of Pathology/Renal Pathology Society classification, separately, by two renal pathologists blinded to the previous classification. Univariate and multivariate analyses were performed using the Cox proportional hazard regression model to identify independent risk factors for chronic kidney disease in lupus nephritis patients. Results Eighteen of 88 patients (20.5%) developed chronic kidney disease during a mean follow-up of 47.6 months (range: 12–96 months). Patients who developed chronic kidney disease were older at onset of lupus nephritis, had less education, and were more likely to have hypertension; they had lower serum albumin levels, lower platelet levels, higher serum creatinine levels, lower estimated glomerular filtration rate, higher chronicity index, and lower frequency of anti-ribosomal P antibodies, and they were less likely to be in complete remission in the first year. In stepwise multivariable analyses, hypertension, lower glomerular filtration rate, and failure to achieve complete remission in the first year of treatment were significant predictors of the development of chronic kidney disease in lupus nephritis patients. Conclusions These findings suggest that patients with hypertension and decreased kidney function at the onset of lupus nephritis and showing a poor response to immunosuppressive drugs in the first year should be monitored carefully and managed aggressively to avoid deterioration of kidney function.
Collapse
Affiliation(s)
- D J Park
- Division of Rheumatology, Chonnam National University Medical School & Hospital, Gwangju, Republic of Korea
| | - J H Kang
- Division of Rheumatology, Chonnam National University Medical School & Hospital, Gwangju, Republic of Korea
| | - J W Lee
- Division of Rheumatology, Chonnam National University Medical School & Hospital, Gwangju, Republic of Korea
| | - K E Lee
- Division of Rheumatology, Chonnam National University Medical School & Hospital, Gwangju, Republic of Korea
| | - T J Kim
- Division of Rheumatology, Chonnam National University Medical School & Hospital, Gwangju, Republic of Korea
| | - Y W Park
- Division of Rheumatology, Chonnam National University Medical School & Hospital, Gwangju, Republic of Korea
| | - J S Lee
- Department of Pathology, Chonnam National University Hospital & Medical School, Gwangju, Republic of Korea
| | - Y D Choi
- Department of Pathology, Chonnam National University Hospital & Medical School, Gwangju, Republic of Korea
| | - S S Lee
- Division of Rheumatology, Chonnam National University Medical School & Hospital, Gwangju, Republic of Korea
| |
Collapse
|
83
|
Oh CM, Chun S, Lee JE, Lee JS, Park S, Gee HY, Kim SW. A novel missense mutation in NR0B1 causes delayed-onset primary adrenal insufficiency in adults. Clin Genet 2017; 92:344-346. [PMID: 28075027 DOI: 10.1111/cge.12966] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2016] [Revised: 01/09/2017] [Accepted: 01/09/2017] [Indexed: 11/28/2022]
Abstract
A novel missense mutation (c.775T>C; p.ser259Pro) in the NROBI gene cause a late-onset adrenal insufficiency without hypogonadism.
Collapse
Affiliation(s)
- C-M Oh
- Department of Internal Medicine, CHA Bundang Medical Center, School of Medicine CHA University, Seongnam, Korea
| | - S Chun
- Department of Internal Medicine, CHA Bundang Medical Center, School of Medicine CHA University, Seongnam, Korea
| | - J-E Lee
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul, Korea
| | - J S Lee
- Department of Pharmacology, Brain Korea 21 Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Korea
| | - S Park
- Department of Biochemistry, College of Medicine, Catholic Kwandong University, Gangneung, Korea
| | - H Y Gee
- Department of Pharmacology, Brain Korea 21 Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Korea
| | - S W Kim
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.,Department of Internal Medicine, Boramae Medical Center, Seoul, Korea
| |
Collapse
|
84
|
Park S, Lee JS, Kim JH, Lim SM, Park HS, Kim SI. Abstract P5-16-25: Serum 25-hydroxyvitamin D levels and oncologic outcomes of breast cancer patients receiving neoadjuvant chemotherapy. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p5-16-25] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background:According to prior studies, the role of serum vitamin D3 has been inconsistentand clinical implications of 25-hyrdoxyvitamin D (25-OHD) have been little studiedin breast cancer patients receiving neoadjuvant chemotherapy (NCT).
Objectives: The aims of study were to investigate changes in 25-OHD levels before and after NCT and to determine the association of 25-OHD and oncologic outcomes including pathological complete response (pCR) in breast cancer patients.
Patients and Materials: From January 2010 to December 2013, serum 25-OHD levels at pre- and post-NCT were measured in 377 breast cancer patients. The association of serum 25-OHD levels with clinicopathological data including breast cancer subtypes, pCR and survival were retrospectively analysed. Delta 25-OHD was calculated as serum 25-OHDlevels before minus after NCT.
Results: Mean ageof study population was 48.7 yearsand mean follow-up periods were 35.9months.Mean baseline serum 25-OHD concentration was 14.60 ng/mL (standard deviation, 7.44) and more than 80% of patients showed insufficient 25-OHD levels. The mean 25-OHDat post-NCT was 12.16 ng/mL (standard deviation, 6.87).There was a significant decrease in serum 25-OHD after NACT (p<0.001).The pCR rates were 25.7% among study cohort.However, 25-OHD levels at baseline and post-NCT were not related to pCR and survival outcomes. No associations were found between pCR and delta 25-OHD. According to stratification by breast cancer subtypes, however, patients with ≥ -2.67 (median value) of delta 25-OHD revealed a trend of higher achievement of pCR and better survival in luminal A subtype. No associations were found among the other subtypes.
Conclusions: Many Korean breast cancer patients showed insufficient serum 25-OHD levels at diagnosis of malignancy and a significant decrease in serum vitamin D3 after NACT was observed.No significant association of 25-OHD 3 with pCR and survival was found. Therefore, correction or maintenance of appropriate serum 25-OHD levels should be focused for bone health as comprehensive management of breast cancer during NCT.In addition, possible oncological aspects of 25-OHD should further researched individually considering breast subtypes.
Citation Format: Park S, Lee JS, Kim JH, Lim SM, Park HS, Kim SI. Serum 25-hydroxyvitamin D levels and oncologic outcomes of breast cancer patients receiving neoadjuvant chemotherapy [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P5-16-25.
Collapse
Affiliation(s)
- S Park
- Yonsei University College of Medicine, Seoul, Republic of Korea; Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea
| | - JS Lee
- Yonsei University College of Medicine, Seoul, Republic of Korea; Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea
| | - JH Kim
- Yonsei University College of Medicine, Seoul, Republic of Korea; Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea
| | - SM Lim
- Yonsei University College of Medicine, Seoul, Republic of Korea; Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea
| | - HS Park
- Yonsei University College of Medicine, Seoul, Republic of Korea; Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea
| | - SI Kim
- Yonsei University College of Medicine, Seoul, Republic of Korea; Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea
| |
Collapse
|
85
|
Lee JS, Kim GE, Park MH, Yoon JH. Abstract P4-12-11: Up-regulation of SPARC is associated with breast tumor progression and epithelial SPARC expression is correlated with poor survival and MMP-2 expression in patients with breast carcinoma. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p4-12-11] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Secreted protein acidic and rich in cysteine (SPARC) plays a crucial role in the process of tumor invasion and metastasis in many cancers. Matrix metalloproteinases (MMPs) degrade the extracellular matrix and participate in several key processes of invasion and metastasis. The aims of this study were to evaluate the potential involvement of SPARC in the progression of breast tumor and to determine its association with outcome variables and MMPs expression in patients with breast carcinoma (BC).
Materials and Methods: SPARC expression was examined in 8 pairs of BC tissues and surrounding normal tissues at mRNA and protein levels by quantitative real-time PCR (qRT-PCR), RNAscope in situ hybridization (ISH), Western blotting, and immunohistochemistry techniques. Immunohistochemical staining of SPARC on tissue microarray was done in 26 normal breasts, 76 ductal carcinoma in situ (DCIS), and 198 BC samples. In addition, we performed immunohistochemical staining for MMP-2 and MMP-9 in BC.
Results: SPARC expression at mRNA and protein levels by qRT-PCR and Western blotting was significantly increased in BC tissues compared to the surrounding normal tissues (p < 0.05 and p < 0.01, respectively). RNAscope ISH and immunohistochemistry of SPARC confirmed that SPARC expression was increased in BC tissues compared with their normal tissues and its expression was more pronounced in the stromal compartment than in epithelial compartment. SPARC expression was different among the normal, DCIS and BC groups and epithelial SPARC expression increased progressively from normal breast through DCIS to BC (p < 0.001). In patients with BC, high epithelial SPARC expression was associated with worse disease-free and overall survival (p = 0.002 and p = 0.048, respectively) and independently predicted worse disease-free survival (p = 0.002). Epithelial SPARC expression was significantly correlated with MMP-2 expression (p < 0.05).
Conclusion: Our results suggest that up-regulation of SPARC contributes to breast tumor progression. SPARC expression may be a useful biomarker for the prognostic prediction in patients with BC. SPARC can control extracellular matrix degradation through up-regulation of MMP-2.
Citation Format: Lee JS, Kim G-E, Park MH, Yoon JH. Up-regulation of SPARC is associated with breast tumor progression and epithelial SPARC expression is correlated with poor survival and MMP-2 expression in patients with breast carcinoma [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P4-12-11.
Collapse
Affiliation(s)
- JS Lee
- Chonnam National University Medical School, Gwangju, Republic of Korea
| | - G-E Kim
- Chonnam National University Medical School, Gwangju, Republic of Korea
| | - MH Park
- Chonnam National University Medical School, Gwangju, Republic of Korea
| | - JH Yoon
- Chonnam National University Medical School, Gwangju, Republic of Korea
| |
Collapse
|
86
|
Chung IY, Lee JW, Lee JS, Park YR, Lee Y, Lee SB, Kim HJ, Ko BS, Son BH, Ahn SH. Abstract P6-09-38: Interaction between body mass index and hormone receptor status as a prognostic factor in node-positive breast cancer. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p6-09-38] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Purpose: The aim of this study was to investigate the interaction between BMI at breast cancer diagnosis and the various factors including hormone-receptor, menopausal and nodal status, and to find a specific subgroup where BMI has an effect on breast cancer prognosis.
Methods: We retrospectively analyzed the data of 8,763 non-metastatic invasive breast cancer patients from the Asan Medical Center's research database. Overall survival (OS) and breast cancer-specific survival (BCSS) among BMI groups were compared using the Kaplan-Meier method and Cox proportional hazard model with interaction term.
Results: Only in node-positive breast cancer, there was a significant interaction between obesity (BMI ≥ 30.0 kg/m2) at diagnosis and positive hormone receptor which showed worse overall survival (OS) and breast cancer specific survival (BCSS) than normal weight patients (adjusted hazard ratio [HR] = 1.65, 95% confidence interval [CI] = 1.01 to 2.69 and HR = 1.90, 95% CI = 1.15 to 3.15, respectively). Underweight (BMI<18.50 kg/m2) which interacted with negative hormone receptor status in node-positive breast cancer was associated with decreased OS (HR = 2.01, 95% CI = 1.02 to 3.98) and BCSS (HR = 2.15, 95% CI = 1.08 to 4.26). There was no significant interaction between BMI and hormone receptor status in node-negative setting and BMI did not interact with menopausal status in any population.
Conclusions: BMI interacts with hormone receptor status in node positive setting, thereby playing a role in the breast cancer prognosis.
Citation Format: Chung IY, Lee JW, Lee JS, Park YR, Lee Y, Lee SB, Kim HJ, Ko BS, Son BH, Ahn SH. Interaction between body mass index and hormone receptor status as a prognostic factor in node-positive breast cancer [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P6-09-38.
Collapse
Affiliation(s)
- IY Chung
- Asan Medical Center, Seoul, Republic of Korea
| | - JW Lee
- Asan Medical Center, Seoul, Republic of Korea
| | - JS Lee
- Asan Medical Center, Seoul, Republic of Korea
| | - YR Park
- Asan Medical Center, Seoul, Republic of Korea
| | - Y Lee
- Asan Medical Center, Seoul, Republic of Korea
| | - SB Lee
- Asan Medical Center, Seoul, Republic of Korea
| | - HJ Kim
- Asan Medical Center, Seoul, Republic of Korea
| | - BS Ko
- Asan Medical Center, Seoul, Republic of Korea
| | - BH Son
- Asan Medical Center, Seoul, Republic of Korea
| | - SH Ahn
- Asan Medical Center, Seoul, Republic of Korea
| |
Collapse
|
87
|
Kakish J, Allen KJH, Harkness TA, Krol ES, Lee JS. Novel Dimer Compounds That Bind α-Synuclein Can Rescue Cell Growth in a Yeast Model Overexpressing α-Synuclein. A Possible Prevention Strategy for Parkinson's Disease. ACS Chem Neurosci 2016; 7:1671-1680. [PMID: 27673434 DOI: 10.1021/acschemneuro.6b00209] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
The misfolding of α-synuclein is a critical event in the death of dopaminergic neurons and the progression of Parkinson's disease. Previously, it was suggested that drugs, which bind to α-synuclein and form a loop structure between the N- and C-termini, tend to be neuroprotective, whereas others, which cause a more compact structure, tend to be neurotoxic. To improve the binding to α-synuclein, eight novel compounds were synthesized from a caffeine scaffold attached to (R,S)-1-aminoindan, (R,S)-nicotine, and metformin, and their binding to α-synuclein determined through nanopore analysis and isothermal titration calorimetry. The ability of the dimers to interact with α-synuclein in a cell system was assayed in a yeast model of PD which expresses an AS-GFP (α-synuclein-Green Fluorescent Protein) construct under the control of a galactose promoter. In 5 mM galactose this yeast strain will not grow and large cytoplasmic foci are observed by fluorescent microscopy. Two of the dimers, C8-6-I and C8-6-N, at a concentration of 0.1 μM allowed the yeast to grow normally in 5 mM galactose and the AS-GFP became localized to the periphery of the cell. Both dimers were superior when compared to the monomeric compounds. The presence of the dimers also caused the disappearance of preformed cytoplasmic foci. Nanopore analysis of C8-6-I and C8-6-N were consistent with simultaneous binding to both the N- and C-terminus of α-synuclein but the binding constants were only 105 M-1.
Collapse
Affiliation(s)
- Joe Kakish
- Department of Biochemistry, ‡Drug Discovery and Development Research Group, College
of Pharmacy and Nutrition, and §Department of Anatomy and Cell Biology, University of Saskatchewan, 107 Wiggins Road, Saskatoon, Canada S7N 0W0
| | - Kevin J. H. Allen
- Department of Biochemistry, ‡Drug Discovery and Development Research Group, College
of Pharmacy and Nutrition, and §Department of Anatomy and Cell Biology, University of Saskatchewan, 107 Wiggins Road, Saskatoon, Canada S7N 0W0
| | - Troy A. Harkness
- Department of Biochemistry, ‡Drug Discovery and Development Research Group, College
of Pharmacy and Nutrition, and §Department of Anatomy and Cell Biology, University of Saskatchewan, 107 Wiggins Road, Saskatoon, Canada S7N 0W0
| | - Ed S. Krol
- Department of Biochemistry, ‡Drug Discovery and Development Research Group, College
of Pharmacy and Nutrition, and §Department of Anatomy and Cell Biology, University of Saskatchewan, 107 Wiggins Road, Saskatoon, Canada S7N 0W0
| | - Jeremy S. Lee
- Department of Biochemistry, ‡Drug Discovery and Development Research Group, College
of Pharmacy and Nutrition, and §Department of Anatomy and Cell Biology, University of Saskatchewan, 107 Wiggins Road, Saskatoon, Canada S7N 0W0
| |
Collapse
|
88
|
Chang PY, Saechao FS, Lee J, Haskell SG, Frayne SM, Lee JS. Prevalence and risk of fracture diagnoses in women across the adult life span: a national cross-sectional study. Osteoporos Int 2016; 27:3177-3186. [PMID: 27349559 DOI: 10.1007/s00198-016-3655-y] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/20/2016] [Accepted: 05/26/2016] [Indexed: 12/21/2022]
Abstract
UNLABELLED In a national sample of women veterans, the rate of lower limb fracture diagnosis was the highest across ages 18-74 years; rates of fracture diagnosis of other skeletal sites peaked in women aged 75+. Women with two or more primary care visits or mental healthcare visits had elevated odds of fracture diagnosis. INTRODUCTION We assessed the prevalence and healthcare utilization characteristics associated with a diagnosis of any fracture in women of all adult ages within the Veterans Health Administration. METHODS In 344,488 women during fiscal year 2012, logistic regression models for fracture diagnosis included age, race/ethnicity, residence, number of primary care visits, number of mental healthcare visits, and degree of service-connected disability. RESULTS Lower limb fracture diagnosis was most prevalent across ages 18-74 years and peaked in women aged 55-64 years. In women aged 75+, the prevalence rates of fracture diagnosis at the hip (102, 95 % CI = 88-115 per 10,000 women), upper limb (100, 95 % CI = 87-114 per 10,000 women), and lower limb (84, 95 % CI = 72-97 per 10,000 women) were the highest. Fractures at other skeletal sites peaked in those aged 75+ years. Black women had the lowest odds of a fracture diagnosis, followed by Asian/Pacific Islander and Hispanic women compared to non-Hispanic White (by 25-51 %, P < 0.05). Having two or more primary care visits or any mental health visit was each associated with an increased risk. Women with five or more primary care visits had a 3.36-fold (95 % CI = 3.02-3.75) greater odds than those with no such visit, and separately, women with five or more mental health visits had a 1.51-fold (95 % CI = 1.43-1.60) greater odds. Women with a fracture diagnosis had higher overall healthcare costs than those without (P < 0.001). CONCLUSIONS Prevalence of fracture diagnosis differed by age, race/ethnicity, and skeletal site of fracture. Fracture diagnosis may identify women veterans with greater overall healthcare needs.
Collapse
Affiliation(s)
- P Y Chang
- Division of Endocrinology, Gerontology, and Metabolism, Department of Medicine, Stanford University, Stanford, CA, USA
| | - F S Saechao
- Medical Services, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, 94304, USA
- VA HSR&D Center for Innovation to Implementation (Ci2i), VA Palo Alto Health Care System, Palo Alto, CA, USA
| | - J Lee
- Medical Services, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, 94304, USA
- VA HSR&D Center for Innovation to Implementation (Ci2i), VA Palo Alto Health Care System, Palo Alto, CA, USA
| | - S G Haskell
- VA Connecticut Healthcare System; Women's Health Services, Veterans Health Administration, West Haven, CT, USA
- General Internal Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT, USA
| | - S M Frayne
- Medical Services, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, 94304, USA
- VA HSR&D Center for Innovation to Implementation (Ci2i), VA Palo Alto Health Care System, Palo Alto, CA, USA
- Division of General Medical Disciplines, Stanford University School of Medicine, Stanford, CA, USA
| | - J S Lee
- Division of Endocrinology, Gerontology, and Metabolism, Department of Medicine, Stanford University, Stanford, CA, USA.
- Medical Services, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, 94304, USA.
- VA HSR&D Center for Innovation to Implementation (Ci2i), VA Palo Alto Health Care System, Palo Alto, CA, USA.
- VA Palo Alto Cooperative Studies Program Coordinating Center, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA.
| |
Collapse
|
89
|
Jakova E, Lee JS. Behavior of α-synuclein-drug complexes during nanopore analysis with a superimposed AC field. Electrophoresis 2016; 38:350-360. [PMID: 27570136 DOI: 10.1002/elps.201600253] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2016] [Revised: 08/17/2016] [Accepted: 08/17/2016] [Indexed: 11/07/2022]
Abstract
Seven α-synuclein-drug complexes have been studied by nanopore analysis in which an AC field of 200 mV from 10 MHz to 1 GHz has been superimposed on the standard electrophoretic DC voltage of 100 mV. α-Synuclein has a large dipole moment and in the absence of drug the AC field causes the molecule to oscillate at the entrance to the pore and reduces its ability to translocate through the pore. Thus more bumping events are observed in the current blockade histograms. The binding of drugs to α-synuclein has a large effect on the event profiles depending on the region of α-synuclein to which the drugs bind. Caffeine and (-)-nicotine bind both the N- and C-termini causing the protein to adopt a loop conformation that allows translocation even in the AC field. Metformin, which binds only to the C-terminus also facilitates translocation. For these drugs there is good evidence that the AC field is causing the complex to dissociate as it enters the pore that has not been observed previously. In contrast, complexes with (+)-amphetamine that has an N-terminal binding site and cocaine that binds to the central region of the protein, show only small changes in the event profiles in an AC field.
Collapse
Affiliation(s)
- Elisabet Jakova
- Department of Biochemistry, University of Saskatchewan, Saskatoon, SK, Canada
| | - Jeremy S Lee
- Department of Biochemistry, University of Saskatchewan, Saskatoon, SK, Canada
| |
Collapse
|
90
|
Lee JS, Kim MJ, Park SH, Lee SB, Wang T, Jung US, Im J, Kim EJ, Lee KW, Lee HG. Effects of dietary mixture of garlic (Allium sativum), coriander (Coriandrum sativum) and probiotics on immune responses and caecal counts in young laying hens. J Anim Physiol Anim Nutr (Berl) 2016; 101:e122-e132. [PMID: 27678135 DOI: 10.1111/jpn.12573] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2015] [Accepted: 06/16/2016] [Indexed: 11/27/2022]
Abstract
This study was conducted to evaluate the effects of a combined mixture of phytogenic extracts (garlic and coriander) and probiotics on growth performance and immune responses in laying hens based on the results of in vitro studies to screen for immunomodulatory potency of each ingredient. Several parameters of immunomodulatory potency were estimated using lamina propria leucocytes (LPLs) isolated from rat intestinal mucosa tissue. Results show that the combined mixture enhanced LPLs proliferation, increased LPL-mediated cytotoxicity against YAC-1 tumour cells, and decreased lipopolysaccharide (LPS)-induced cytokine production including tumour necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) in LPLs. For in vivo study, laying hens (n = 50/each diet group) were fed with control diet, a diet containing antibiotics (0.01% per kg feed) or the combined mixture (0.02% per kg feed) for 21 days. The dietary combined mixture improved egg production (p < 0.05) but not growth performance and carcass traits. Interestingly, the patterns of suppressing plasma IFN-γ productions during inflammation by LPS injection and decreasing caecal E. coli counts in the combined mixture group were comparable to those in the antibiotics group. Taken together, our results suggested that the 0.02% of combined mixture of phytogenic extracts and probiotics as ingredients has potential immunomodulatory effects in laying hens.
Collapse
Affiliation(s)
- J S Lee
- Department of Animal Science and Technology, College of Animal Bioscience & Technology, Konkuk University, Gwangjin-gu, Seoul, Korea.,Team of An Educational Program for Specialists in Global Animal Science, Brain Korea 21 Plus Project, Konkuk University, Gwangjin-gu, Seoul, Korea
| | - M J Kim
- Department of Animal Science and Technology, College of Animal Bioscience & Technology, Konkuk University, Gwangjin-gu, Seoul, Korea
| | - S H Park
- Department of Animal Science, College of Natural Resources and Life Science, Pusan National University, Gyeongnam, Korea
| | - S B Lee
- Department of Animal Science and Technology, College of Animal Bioscience & Technology, Konkuk University, Gwangjin-gu, Seoul, Korea
| | - T Wang
- College of Animal Science and Technology, Jilin Agricultural University, Changchun, China
| | - U S Jung
- Department of Animal Science and Technology, College of Animal Bioscience & Technology, Konkuk University, Gwangjin-gu, Seoul, Korea
| | - J Im
- Department of Medicine, University of Minnesota, Minneapolis, MN, USA
| | - E J Kim
- Division of Animal Husbandry, College of Chonan Yonam, Cheonan-si, Chungnam, Korea
| | - K W Lee
- Department of Animal Science and Technology, College of Animal Bioscience & Technology, Konkuk University, Gwangjin-gu, Seoul, Korea.,Team of An Educational Program for Specialists in Global Animal Science, Brain Korea 21 Plus Project, Konkuk University, Gwangjin-gu, Seoul, Korea
| | - H G Lee
- Department of Animal Science and Technology, College of Animal Bioscience & Technology, Konkuk University, Gwangjin-gu, Seoul, Korea.,Team of An Educational Program for Specialists in Global Animal Science, Brain Korea 21 Plus Project, Konkuk University, Gwangjin-gu, Seoul, Korea
| |
Collapse
|
91
|
Jung SA, Lee DH, Moon JH, Hong SW, Shin JS, Hwang IY, Shin YJ, Kim JH, Gong EY, Kim SM, Lee EY, Lee S, Kim JE, Kim KP, Hong YS, Lee JS, Jin DH, Kim T, Lee WJ. Corrigendum to 'L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells': [Free Radic. Biol. Med. 95 (2016) 200-208]. Free Radic Biol Med 2016; 97:620. [PMID: 27476024 DOI: 10.1016/j.freeradbiomed.2016.07.017] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Affiliation(s)
- S A Jung
- Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea
| | - D H Lee
- Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea; Biomedical Science and Engineering Interdisciplinary Program, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon, Republic of Korea
| | - J H Moon
- Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea
| | - S W Hong
- Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea
| | - J S Shin
- Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea
| | - I Y Hwang
- Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea
| | - Y J Shin
- Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea
| | - J H Kim
- Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea
| | - E Y Gong
- Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea
| | - S M Kim
- Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea
| | - E Y Lee
- Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea
| | - S Lee
- Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea
| | - J E Kim
- Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea
| | - K P Kim
- Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea
| | - Y S Hong
- Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea
| | - J S Lee
- Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea
| | - D H Jin
- Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea; Department of Convergence Medicine, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea.
| | - T Kim
- Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea.
| | - W J Lee
- Department of Anatomy and Tumor Immunity Medical Research Center, Seoul National University College of Medicine, Seoul 110-744, Republic of Korea
| |
Collapse
|
92
|
Kim YW, Hong JM, Park DG, Choi JW, Kang DH, Kim YS, Zaidat OO, Demchuk AM, Hwang YH, Lee JS. Effect of Intracranial Atherosclerotic Disease on Endovascular Treatment for Patients with Acute Vertebrobasilar Occlusion. AJNR Am J Neuroradiol 2016; 37:2072-2078. [PMID: 27313131 DOI: 10.3174/ajnr.a4844] [Citation(s) in RCA: 105] [Impact Index Per Article: 13.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2015] [Accepted: 04/24/2016] [Indexed: 02/01/2023]
Abstract
BACKGROUND AND PURPOSE Although intracranial atherosclerotic disease is often encountered during endovascular treatment for acute vertebrobasilar occlusions, its clinical implication is not well-known. We aimed to evaluate whether intracranial atherosclerotic disease influences the clinical outcomes following endovascular treatment of acute vertebrobasilar occlusive stroke. MATERIALS AND METHODS Fifty-one patients with acute vertebrobasilar occlusive stroke were included. The onset-to-groin puncture time was ≤12 hours, and aspiration- or stent-based thrombectomy was used as the primary treatment method. Following primary endovascular treatment, intracranial atherosclerotic disease (IAD group) was angiographically diagnosed when a fixed focal stenosis was observed at the occlusion site, whereas embolism (embolic group) was diagnosed if no stenosis was observed. Clinical and treatment variables were compared in both groups, and IAD was evaluated as a prognostic factor for clinical outcomes. RESULTS The baseline NIHSS score tended to be lower (14 versus 22, P = .097) in the IAD group (n = 19) than in the embolic group (n = 32). The procedural time was longer in the IAD group (96 versus 61 minutes, P = .002), despite similar rates of TICI 2b-3 (89.5% versus 87.5%, P = 1.000). The NIHSS score at 7 days was higher (21 versus 8, P = .060) and poor outcomes (mRS 4-6 at 3 months) were more frequent in the IAD group (73.7% versus 43.8%, P = .038). IAD (odds ratio, 5.469; 95% CI, 1.09-27.58; P = .040) was independently associated with poor outcomes. CONCLUSIONS An arterial occlusion related to IAD was associated with a longer procedural time and poorer clinical outcome. Further studies are warranted to elucidate the appropriate endovascular strategy.
Collapse
Affiliation(s)
- Y W Kim
- From the Departments of Neurology (Y.W.K., Y.H.H.).,Radiology (Y.W.K., D.-H.K., Y.S.K.)
| | - J M Hong
- Departments of Neurology (J.M.H., D.G.P., J.S.L.)
| | - D G Park
- Departments of Neurology (J.M.H., D.G.P., J.S.L.)
| | - J W Choi
- Radiology (J.W.C.), Ajou University School of Medicine and Hospital, Suwon, Republic of Korea
| | - D-H Kang
- Radiology (Y.W.K., D.-H.K., Y.S.K.).,Neurosurgery (D.-H.K.), Kyungpook National University School of Medicine and Hospital, Daegu, Republic of Korea
| | - Y S Kim
- Radiology (Y.W.K., D.-H.K., Y.S.K.)
| | - O O Zaidat
- Radiology (J.W.C.), Ajou University School of Medicine and Hospital, Suwon, Republic of Korea
| | - A M Demchuk
- Radiology (J.W.C.), Ajou University School of Medicine and Hospital, Suwon, Republic of Korea
| | - Y H Hwang
- From the Departments of Neurology (Y.W.K., Y.H.H.)
| | - J S Lee
- Departments of Neurology (J.M.H., D.G.P., J.S.L.)
| |
Collapse
|
93
|
Lee JS, Lee SM, Jeong SW, Sung YG, Lee JH, Kim KW. Effects of age, replicative lifespan and growth rate of human nucleus pulposus cells on selecting age range for cell-based biological therapies for degenerative disc diseases. Biotech Histochem 2016; 91:377-85. [PMID: 27149303 DOI: 10.1080/10520295.2016.1179790] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
Autologous disc cell implantation, growth factors and gene therapy appear to be promising therapies for disc regeneration. Unfortunately, the replicative lifespan and growth kinetics of human nucleus pulposus (NP) cells related to host age are unclear. We investigated the potential relations among age, replicative lifespan and growth rate of NP cells, and determined the age range that is suitable for cell-based biological therapies for degenerative disc diseases. We used NP tissues classified by decade into five age groups: 30s, 40s, 50s, 60s and 70s. The mean cumulative population doubling level (PDL) and population doubling rate (PDR) of NP cells were assessed by decade. We also investigated correlations between cumulative PDL and age, and between PDR and age. The mean cumulative PDL and PDR decreased significantly in patients in their 60s. The mean cumulative PDL and PDR in the younger groups (30s, 40s and 50s) were significantly higher than those in the older groups (60s and 70s). There also were significant negative correlations between cumulative PDL and age, and between PDR and age. We found that the replicative lifespan and growth rate of human NP cells decreased with age. The replicative potential of NP cells decreased significantly in patients 60 years old and older. Young individuals less than 60 years old may be suitable candidates for NP cell-based biological therapies for treating degenerative disc diseases.
Collapse
Affiliation(s)
- J S Lee
- a Departments of Orthopedic Surgery , Seoul , Korea
| | - S M Lee
- a Departments of Orthopedic Surgery , Seoul , Korea
| | - S W Jeong
- b Orthopedic Research, Medical Research Institute , Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea , Seoul , Korea
| | - Y G Sung
- a Departments of Orthopedic Surgery , Seoul , Korea
| | - J H Lee
- a Departments of Orthopedic Surgery , Seoul , Korea
| | - K W Kim
- a Departments of Orthopedic Surgery , Seoul , Korea
| |
Collapse
|
94
|
Yeo YW, Oon HH, Lee JS, Pan JY, Mok YJ, Ng SK. Papular angiolymphoid hyperplasia and lymphoplasmacytic plaque: a clinical and histological spectrum. Dermatol Online J 2016; 22:13030/qt9qq3d88q. [PMID: 27617464] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2016] [Accepted: 04/18/2016] [Indexed: 06/06/2023] Open
Abstract
Acral pseudolymphomatous angiokeratoma of children (APACHE) is a rare form of cutaneous pseudolymphoma characterized byangiomatous papules with a predilection for the acral regions of children. Classically, a dense dermal lymphocytic infiltrate composed of both T and B cells is seen in histological specimens, together with prominent vessels lined by plump endothelial cells. Increasing evidence suggests that this condition is neither necessarily acral, pseudolymphomatous, nor angiokeratomatous. It may not always be a pediatric disease. Therefore, the correctness of its nomenclature has been questioned. Herein, we report threecases whose clinical and histological features were consistent with the diagnosis of APACHE. To our knowledge, this is the first report of APACHE from Southeast Asia. We also discuss why we believe "APACHE" to be a misnomer and support "papular angiolymphoid hyperplasia" as a more accurate and encompassing term. In addition, we illustrate a case with significant overlapping features with lymphoplasmacytic plaque in children, suggesting that both entities may exist on a clinical andhistological spectrum.
Collapse
|
95
|
Kim MA, Noh CS, Chang YJ, Hong YK, Lee JS, Lee SW, Lee SD, Oh YM. Asthma and COPD overlap syndrome is associated with increased risk of hospitalisation. Int J Tuberc Lung Dis 2016; 19:864-9. [PMID: 26056115 DOI: 10.5588/ijtld.14.0327] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Chronic obstructive pulmonary disease (COPD) is associated with poor prognosis and a high health care burden. The incidence of asthma and COPD overlap syndrome is increasing, and contributes to a high financial burden and poor prognosis. OBJECTIVE To investigate clinical features of the overlap syndrome among Asian patients and to analyse its impact on hospitalisation due to respiratory problems or death compared to COPD alone. DESIGN We performed a retrospective cohort analysis of 2933 COPD patients presenting at the Asan Medical Center from 1 January 2000 to 31 December 2009. Kaplan-Meier and Cox proportional hazard models were used to analyse the significance of clinical parameters, including age, sex, smoking history, body mass index (BMI), severity of airflow limitation, airway obstruction reversibility and overlap syndrome with hospitalisation due to respiratory problems or death. RESULTS Overlap syndrome patients were older, included smaller proportions of males and of smokers and had lower forced expiratory volume in 1 s (FEV1) (% predicted). Shorter hospitalisation-free and survival periods were noted among overlap syndrome patients. Overlap syndrome was significantly associated with risk of hospitalisation due to respiratory problems after adjusting for age, smoking history, BMI, FEV1 (% predicted) and changes in FEV1 (P < 0.001). CONCLUSION Asthma and COPD overlap syndrome is associated with a higher risk of hospitalisation due to respiratory problems than COPD alone.
Collapse
Affiliation(s)
- M-A Kim
- Department of Allergy and Clinical Immunology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea
| | - C S Noh
- Department of Internal Medicine, Seoul Seonam Hospital, Ewha Womans University Medical Center, Seoul, Republic of Korea
| | - Y-J Chang
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea
| | - Y-K Hong
- Department of Internal Medicine, Kangwon National University Hospital, Chuncheon, Republic of Korea
| | - J S Lee
- Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - S W Lee
- Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - S-D Lee
- Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - Y-M Oh
- Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| |
Collapse
|
96
|
Lee JS, Kim GE, Park MH, Yoon JH. Abstract P2-07-06: Periostin is associated with breast tumor progression and epithelial periostin expression is correlated with poor survival in patients with invasive breast carcinoma. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p2-07-06] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Invasion and metastasis are the direct causes of mortality in patients with breast cancer and require reciprocal interactions between cancer cells and the extracellular matrix (ECM). Periostin, a fasciclin-containing adhesive ECM glycoprotein, is frequently overexpressed in various types of human cancer, and its overexpression in cancer-associated stroma and/or cancer cells is usually associated with poor clinical outcomes. However, the expression of periostin in the successive steps of breast tumorigenesis and its association with outcome variables have not been well established in breast carcinoma. The purposes of the present study were to assess the role of periostin alteration in breast tumorigenesis and evaluate the putative prognostic value of periostin as a function of its compartmentalization.
Materials and Methods: Immunohistochemical staining with anti-periostin antibody was performed in a total of 300 patients (26 patients with normal breasts, 76 patients with ductal carcinoma in situ [DCIS], and 198 patients with invasive breast carcinoma [IBC]) using tissue microarray. Periostin immunoreactivity was assessed in both epithelial tissue and the surrounding stromal compartment. In addition, the mRNA and protein expression of periostin was analyzed in 10 paired normal/invasive cancer frozen specimens by quantitative real time-polymerase chain reaction and western blot analysis, respectively.
Results: Periostin mRNA and protein expression in cancer tissues was increased compared with that in adjacent normal tissues. Both epithelial and stromal periostin staining scores were significantly increased with disease progression in a stepwise manner to DCIS and IBC compared with those in normal breast tissues (P = 0.000 and 0.000, respectively). High epithelial and stromal periostin expression was observed in 109 of 189 (57.7%) and 158 of 189 (83.6%) cases of IBC, respectively. High epithelial periostin expression was more frequently observed in the distant metastatic relapse-positive group than in the distant metastatic relapse-negative group (41 [80.4%] of 51 cases versus 68 [49.3%] of 138 cases [P = 0.000]). Furthermore, high epithelial periostin expression was associated with reduced disease-free and overall survival on univariate and multivariate analyses.
Conclusion: Periostin might play an important role in the progression of breast tumor, and epithelial periostin expression may serve as a new parameter for prognostic prediction in patients with IBC. Further study of periostin expression and its potential as a target of therapy for IBC appears warranted.
Citation Format: Lee JS, Kim G-E, Park MH, Yoon JH. Periostin is associated with breast tumor progression and epithelial periostin expression is correlated with poor survival in patients with invasive breast carcinoma. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P2-07-06.
Collapse
Affiliation(s)
- JS Lee
- Chonnam National University Medical School, Gwangju, Republic of Korea
| | - G-E Kim
- Chonnam National University Medical School, Gwangju, Republic of Korea
| | - MH Park
- Chonnam National University Medical School, Gwangju, Republic of Korea
| | - JH Yoon
- Chonnam National University Medical School, Gwangju, Republic of Korea
| |
Collapse
|
97
|
Cho J, Yi Y, Ahn TK, Choi HJ, Park CH, Chun DI, Lee JS, Lee WC. Failure to restore sagittal tibiotalar alignment in total ankle arthroplasty: Its relationship to the axis of the tibia and the positioning of the talar component. Bone Joint J 2016; 97-B:1525-32. [PMID: 26530656 DOI: 10.1302/0301-620x.97b11.33636] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
The purpose of this study was to evaluate the change in sagittal tibiotalar alignment after total ankle arthroplasty (TAA) for osteoarthritis and to investigate factors affecting the restoration of alignment. This retrospective study included 119 patients (120 ankles) who underwent three component TAA using the Hintegra prosthesis. A total of 63 ankles had anterior displacement of the talus before surgery (group A), 49 had alignment in the normal range (group B), and eight had posterior displacement of the talus (group C). Ankles in group A were further sub-divided into those in whom normal alignment was restored following TAA (41 ankles) and those with persistent displacement (22 ankles). Radiographic and clinical results were assessed. Pre-operatively, the alignment in group A was significantly more varus than that in group B, and the posterior slope of the tibial plafond was greater (p < 0.01 in both cases). The posterior slope of the tibial component was strongly associated with restoration of alignment: ankles in which the alignment was restored had significantly less posterior slope (p < 0.001). An anteriorly translated talus was restored to a normal position after TAA in most patients. We suggest that surgeons performing TAA using the Hintegra prosthesis should aim to insert the tibial component at close to 90° relative to the axis of the tibia, hence reducing posterior soft-tissue tension and allowing restoration of normal tibiotalar alignment following surgery.
Collapse
Affiliation(s)
- J Cho
- Seoul Paik Hospital, No. 85 2-Ga, Jeo-Dong, Jung-Gu, Seoul, 100-032, Republic of Korea
| | | | - T K Ahn
- Bundang CHA Hospital, No. 351, Yatap-Dong, Bundang-Gu, Sungnam, Kyunggi-Do, 463-070, Republic of Korea
| | - H J Choi
- Haeundae Paik Hospital, No. 875, Haeundae-Ro, Haeundae-Gu, Busan, 612-896, Republic of Korea
| | - C H Park
- Yeung-Nam University Hospital, No. 170, Hyunchung-Ro, Nam-Gu, Daegu, 705-040, Republic of Korea
| | - D I Chun
- Soonchunhyang University Medical Center, No. 59, Daesagwan-Ro, Yongsan-Gu, Seoul, 140-743, Republic of Korea
| | - J S Lee
- Asan Medical Center, Pungnap 2(i)-dong Songpa-gu Seoul, Republic of Korea
| | - W C Lee
- Seoul Paik Hospital, No. 85 2-Ga, Jeo-Dong, Jung-Gu, Seoul, 100-032, Republic of Korea
| |
Collapse
|
98
|
Wu PT, Lee JS, Wu KC, Wu TT, Shao CJ, Liang FW, Chern TC, Su FC, Jou IM. Ultrasound-Guided Percutaneous Radiofrequency Lesioning When Treating Recalcitrant Plantar Fasciitis: Clinical Results. Ultraschall Med 2016; 37:56-62. [PMID: 25389914 DOI: 10.1055/s-0034-1385466] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
PURPOSE We evaluated the effects of ultrasound (US)-guided percutaneous radiofrequency thermal lesioning (RTL) and the impact of obesity when treating patients with recalcitrant plantar fasciitis. MATERIALS AND METHODS 30 consecutive patients were enrolled. The visual analog scale (VAS), American Orthopedic Foot-Ankle Society (AOFAS) Ankle-Hindfoot Score, and plantar fascia thickness measured using US were recorded at baseline and at follow-up 1, 3, 6, and 12 months after surgery under local anesthesia. RESULTS 12 patients in the obese (BMI ≥ 30 kg/m(2)) group and 18 patients in the non-obese group. There were significant postoperative decreases in VAS scores and in fascial thickness, and an increase in the AOFAS scores (all p < 0.001). The obese group showed delayed pain and functional improvement within the first 3 months after the index procedure (p < 0.01). Significant pain reduction and functional improvement were apparent earlier (after 1 month, p < 0.001) in the non-obese group than in the obese group (after 3 months, p < 0.05). Fascia thickness was positively correlated with the VAS score and negatively correlated with the AOFAS score (both p < 0.001). CONCLUSION US should be regarded as a useful objective tool to guide RTL and to monitor the effectiveness of treatment. US-guided percutaneous RTL for recalcitrant PF is a minimally invasive treatment option that yields satisfactory results. Therefore, it should at least be considered before using more invasive procedures. Moreover, obesity leads to delayed improvement but does not affect overall outcome after 12 months. Plantar fascial thickness was correlated with VAS and AOFAS scores.
Collapse
Affiliation(s)
- P T Wu
- Department of Orthopaedics, National Cheng Kung University Hopistal, Tainan, Taiwan
| | - J S Lee
- Division of Neurosurgery, Department of Surgery, National Cheng Kung University Hopistal, Tainan, Taiwan
| | - K C Wu
- Institute of Biomedical Engineering, National Cheng Kung University, Tainan, Taiwan
| | - T T Wu
- Institute of Biomedical Engineering, National Cheng Kung University, Tainan, Taiwan
| | - C J Shao
- Department of Orthopaedics, Tainan Municipal Hospital, Tainan, Taiwan
| | - F W Liang
- Institute of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan
| | - T C Chern
- Chern Tai-Chung's Orthopedics Clinic, Tainan, Taiwan
| | - F C Su
- Institute of Biomedical Engineering, National Cheng Kung University, Tainan, Taiwan
| | - I M Jou
- Department of Orthopaedics, National Cheng Kung University Hopistal, Tainan, Taiwan
| |
Collapse
|
99
|
Jeon KS, Sung JH, Lee MW, Song HY, Shin HY, Park WH, Jang YI, Kang MG, Choi YH, Lee JS, Ko DH, Ryu HY. A Study of Piezoelectric Field Related Strain Difference in GaN-Based Blue Light-Emitting Diodes Grown on Silicon(111) and Sapphire Substrates. J Nanosci Nanotechnol 2016; 16:1798-1801. [PMID: 27433673 DOI: 10.1166/jnn.2016.11939] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
We investigate the strain difference in InGaN/GaN multiple quantum wells of blue light-emitting diode (LED) structures grown on silicon(1 11) and c-plane sapphire substrates by comparing the strength of piezo-electric fields in MQWs. The piezo-electric fields for two LED samples grown on silicon and sapphire substrates are measured by using the reverse-bias electro-reflectance (ER) spectroscopy. The flat-band voltage is obtained by measuring the applied reverse bias voltage that induces a phase inversion in the ER spectra, which is used to calculate the strength of piezo-electric fields. The piezo-electric field is determined to be 1.36 MV/cm for the LED on silicon substrate and 1.83 MV/cm for the LED on sapphire substrate. The ER measurement results indicate that the strain-induced piezo-electric field is greatly reduced in the LED grown on silicon substrates consistent with previous strain measurement results by micro-Raman spectroscopy and high-resolution transmission electron microscopy.
Collapse
|
100
|
Lee JS, Yoo Y, Lim BC, Kim KJ, Choi M, Chae JH. SATB2-associated syndrome presenting with Rett-like phenotypes. Clin Genet 2016; 89:728-32. [PMID: 26596517 DOI: 10.1111/cge.12698] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2015] [Revised: 11/18/2015] [Accepted: 11/19/2015] [Indexed: 11/30/2022]
Abstract
The SATB2-associated syndrome (SAS) was proposed recently, after the SATB2 gene was initially discovered to be associated with isolated cleft palate. This syndrome is characterized by intellectual disability with delayed speech development, facial dysmorphism, cleft or high-arched palate, and dentition problems. Here, we describe two novel SATB2 sequence variants in two unrelated patients presenting with Rett-like phenotypes. We performed trio-based whole-exome sequencing in a 17-month-old girl presenting with severe retardation and Rett-like phenotypes, which revealed a de novo missense variant in SATB2 (p.Glu396Gln). Moreover, targeted sequencing of the SATB2 gene was performed in a 2-year-old girl with severe psychomotor retardation, facial hypotonia, and cleft palate who also exhibited some features of Rett syndrome. A nonsense variant in SATB2 was identified in this patient (p.Arg459*). This study expanded the clinical and genetic spectrum of SAS. SATB2 variants should be considered in cases with psychomotor retardation alone or in any cases with Rett-like phenotypes, regardless of the typical features of SAS such as cleft palate.
Collapse
Affiliation(s)
- J S Lee
- Department of Pediatrics, Gachon University Gil Medical Center, Incheon, South Korea
| | - Y Yoo
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea
| | - B C Lim
- Department of Pediatrics, Pediatric Clinical Neuroscience Center, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, South Korea
| | - K J Kim
- Department of Pediatrics, Pediatric Clinical Neuroscience Center, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, South Korea
| | - M Choi
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea
| | - J-H Chae
- Department of Pediatrics, Pediatric Clinical Neuroscience Center, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, South Korea
| |
Collapse
|